Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: POOL AIT CNM WSO SITE WCC MSM FAST FERG GWW

| Held by: IJR VTI VB IWM VBR VXF SPSM VTWO IWN DFAT

Index	RUT
Market Cap	3.19B
Enterprise Value	6.63B
Income	349.00M
Sales	7.65B
Book/sh	16.66
Cash/sh	6.25
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	14800
IPO	Oct 15, 2018

P/E	9.30
Forward P/E	10.22
PEG	0.90
P/S	0.42
P/B	1.26
P/C	3.36
P/FCF	-
EV/EBITDA	7.91
EV/Sales	0.87
Quick Ratio	1.41
Current Ratio	2.22
Debt/Eq	1.30
LT Debt/Eq	1.27
Option/Short	Yes / Yes

EPS (ttm)	2.26
EPS next Y	2.06
EPS next Q	0.47
EPS this Y	10.38%
EPS next Y	-0.04%
EPS next 5Y	11.39%
EPS past 3/5Y	- -
Sales past 3/5Y	5.46% 8.06%
EPS Y/Y TTM	143.16%
Sales Y/Y TTM	3.42%
EPS Q/Q	109.18%
Sales Q/Q	1.96%
Earnings	Aug 12 AMC
EPS/Sales Surpr.	22.96% 2.38%

Insider Own	12.56%
Insider Trans	0.20%
Inst Own	88.91%
Inst Trans	2.66%
ROA	4.94%
ROE	15.20%
ROIC	6.25%
Gross Margin	27.94%
Oper. Margin	8.34%
Profit Margin	4.56%
SMA20	-12.56%
SMA50	-9.15%
SMA200	-13.10%
Trades

Shs Outstand	151.51M
Shs Float	132.78M
Short Float	4.45%
Short Ratio	2.52
Short Interest	5.91M
52W High	31.50 -33.27%
52W Low	18.59 13.10%
Volatility	7.63% 5.36%
ATR (14)	1.51
RSI (14)	38.69
Beta	1.61
Rel Volume	0.00
Avg Volume	2.34M
Volume	0

Perf Week	-13.28%
Perf Month	-14.94%
Perf Quarter	6.97%
Perf Half Y	-17.02%
Perf YTD	-13.95%
Perf Year	-4.94%
Perf 3Y	88.17%
Perf 5Y	3.49%
Perf 10Y	-
Recom	1.50
Target Price	30.83
Prev Close	21.02
Price	21.02
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-26	Resumed	JP Morgan	Neutral	$30
Jul-01-26	Initiated	Seaport Research Partners	Buy	$55
Aug-12-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$35
Jul-30-25	Upgrade	Oppenheimer	Perform → Outperform
Apr-22-25	Downgrade	JP Morgan	Overweight → Neutral	$16
Aug-09-24	Resumed	Evercore ISI	Outperform	$25
Jul-05-23	Resumed	JP Morgan	Overweight	$22
Nov-02-22	Downgrade	Imperial Capital	Outperform → In-line	$27
Mar-17-21	Initiated	Morgan Stanley	Equal-Weight	$33
Mar-11-21	Downgrade	ROTH Capital	Buy → Neutral	$30
Mar-03-21	Initiated	William Blair	Mkt Perform
Feb-26-21	Downgrade	BofA Securities	Buy → Neutral
Dec-21-20	Initiated	JP Morgan	Overweight	$28
Dec-14-20	Initiated	Evercore ISI	Outperform	$25
Nov-06-20	Upgrade	ROTH Capital	Neutral → Buy	$30
Aug-12-20	Upgrade	Imperial Capital	In-line → Outperform
Apr-28-20	Downgrade	Imperial Capital	Outperform → In-line	$12.50 → $6
Apr-03-20	Initiated	ROTH Capital	Neutral	$4
Feb-28-20	Upgrade	Imperial Capital	In-line → Outperform	$10 → $13
Jan-07-20	Upgrade	BofA/Merrill	Neutral → Buy

Show Previous Ratings

Aug-13-26 08:30AM	Resideo Technologies, Inc. Q2 2026 Earnings Call Summary (Moby) -20.42%
Aug-12-26 05:59PM	Resideo Technologies: Q2 Earnings Snapshot (Associated Press) +6.06%
04:06PM	Resideo Appoints Shane Harrison as Chief Financial Officer (PR Newswire)
04:05PM	Resideo Announces Record Second Quarter 2026 Financial Results; Initiates Standalone 2026 Outlook (PR Newswire)
Aug-07-26 09:45AM	SpaceX upgraded, Trade Desk downgraded: Wall Street's top analyst calls (The Fly)
08:55AM	Loading…
Aug-04-26 08:55AM	NYSE Content Update: ADI to Make NYSE Trading Debut After Spin-Off (PR Newswire)
06:00AM	Resideo Technologies Completes Spin-Off of ADI Global Distribution (PR Newswire)
Jul-31-26 05:51PM	Ferguson Enterprises Set to Join S&P 500 and ADI Global Distribution to Join S&P SmallCap 600 (PR Newswire) +5.63%
10:51AM	A spot is opening up in the S&P 500, and these stocks are top candidates to fill the void (MarketWatch)
Jul-28-26 06:00AM	ADI Global Distribution To Report Second Quarter 2026 Financial Results on August 13, 2026 (PR Newswire)
Jul-22-26 04:05PM	Resideo To Release Second Quarter 2026 Financial Results on August 12, 2026 (PR Newswire)
Jul-14-26 06:50AM	ADI Global Distribution Outlines Standalone Strategy and Financial Framework at Inaugural Investor Day (PR Newswire)
Jul-13-26 08:57AM	NYSE Content Update: Circle Shares Come Off 5% Rise After Latest Banking Step (PR Newswire)
06:50AM	Resideo To Present Strategy and Financial Framework as Pure-Play Building Technologies Company at Investor Day (PR Newswire)
Jul-01-26 04:05PM	Resideo Board of Directors Sets Record Date and Announces Expected Timing for Spin-off of ADI Global Distribution (PR Newswire)
04:58PM	Loading…
Jun-16-26 04:58PM	Resideo Announces Pricing of ADI's Offering of Unsecured Senior Notes in Connection with Planned Spin-Off (PR Newswire) -5.71%
Jun-04-26 04:15PM	Resideo Provides Update on Planned Spin-Off of ADI Global Distribution (PR Newswire)
May-14-26 06:16PM	Resideo To Participate at Upcoming Investor Conferences (PR Newswire) -5.75%
May-13-26 08:30AM	Resideo Technologies, Inc. Q1 2026 Earnings Call Summary (Moby) -17.91%
01:00AM	Resideo Technologies Inc (REZI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-12-26 04:16PM	Resideo Technologies: Q1 Earnings Snapshot (Associated Press)
04:05PM	Resideo Announces First Quarter 2026 Financial Results (PR Newswire)
May-11-26 06:15AM	Resideo Announces Filing of Form 10 Registration Statement for Planned Spin-Off of ADI Global Distribution (PR Newswire) -5.74%
Apr-21-26 04:05PM	Resideo To Release First Quarter 2026 Financial Results on May 12, 2026 (PR Newswire)
Mar-10-26 09:23AM	Temporary ERP Implementation Issues Weighed on Resideo Technologies (REZI) in Q4 (Insider Monkey)
Mar-05-26 06:55AM	Janus International Group Announces Two Appointments to Its Board of Directors (Business Wire)
Mar-03-26 12:20PM	Why Resideo Technologies (REZI) Might be Well Poised for a Surge (Zacks)
08:55AM	Fast-paced Momentum Stock Resideo Technologies (REZI) Is Still Trading at a Bargain (Zacks)
Feb-25-26 03:50PM	Why Resideo (REZI) Stock Is Trading Up Today (StockStory) +14.39%
08:30AM	Resideo Technologies, Inc. Q4 2025 Earnings Call Summary (Moby)
05:17AM	Loading…
05:17AM	Resideo Technologies Q4 Earnings Call Highlights (MarketBeat)
12:01AM	Resideo Technologies Inc (REZI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Feb-24-26 08:00PM	Resideo Technologies (REZI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:30PM	Resideo Technologies (REZI) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:51PM	Resideo's (NYSE:REZI) Q4 CY2025 Sales Beat Estimates, Stock Jumps 11.1% (StockStory)
04:50PM	Resideo Technologies: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Resideo Announces Fourth Quarter and Full Year 2025 Financial Results and Initiates 2026 Outlook (PR Newswire)
Feb-22-26 10:12PM	Resideo (REZI) Q4 Earnings: What To Expect (StockStory)
Feb-09-26 04:05PM	Resideo To Participate at Upcoming Investor Conferences (PR Newswire)
Feb-05-26 05:19PM	Resideo Wins Two 2026 IoT Breakthrough Awards for Smart Home Innovation (PR Newswire)
Feb-03-26 11:35PM	3 Profitable Stocks with Warning Signs (StockStory)
04:05PM	Resideo To Release Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (PR Newswire)
Feb-02-26 06:19AM	Zacks Industry Outlook Highlights Allegion, Resideo Technologies, Napco Security Technologies and Intellicheck (Zacks)
Jan-30-26 10:27AM	4 Security & Safety Stocks to Consider on Prospering Industry Trends (Zacks)
Jan-27-26 09:00AM	Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Resideo Technologies, Inc. (NYSE: REZI) (Business Wire)
Jan-21-26 11:04PM	3 Reasons to Avoid REZI and 1 Stock to Buy Instead (StockStory)
Jan-05-26 10:31PM	Reflecting On Building Materials Stocks' Q3 Earnings: Resideo (NYSE:REZI) (StockStory)
Dec-18-25 04:25PM	4 Companies Are Betting on AI Security. Heres Whos Best Positioned. (24/7 Wall St.)
Dec-10-25 11:29AM	Resideo Technologies Inc. (REZI) Unveils Honeywell Home X8S Smart Thermostat with Live Video Streaming Capability (Insider Monkey) +5.30%
Dec-04-25 11:31PM	3 Russell 2000 Stocks with Open Questions (StockStory)
Dec-03-25 11:00AM	Resideo Redefines Smart Comfort with Launch of Honeywell Home X8S Smart Thermostat (PR Newswire)
Dec-02-25 04:10PM	Resideo Announces Sale of Grid Services Demand Response Business to EnergyHub (PR Newswire)
Nov-21-25 07:45PM	Novavax, UniFirst, and More Stocks See Action From Activist Investors (Barrons.com)
Nov-18-25 09:45AM	Carl Icahn Makes Another Huge Insider Purchase (24/7 Wall St.)
Nov-13-25 11:33PM	1 Growth Stock with Explosive Upside and 2 We Find Risky (StockStory) +5.87%
Nov-12-25 04:05PM	Resideo To Participate at Upcoming Investor Events (PR Newswire)
Nov-10-25 12:55PM	Here's Why You Should Retain Allegion Stock in Your Portfolio (Zacks)
Nov-06-25 05:06PM	Why Resideo Technologies Stock Plummeted by Almost 24% on Thursday (Motley Fool) -23.75%
01:56PM	Why Resideo (REZI) Shares Are Sliding Today (StockStory)
09:52AM	4 Security & Safety Stocks to Consider on Promising Industry Trends (Zacks)
12:10AM	Resideo Technologies Inc (REZI) Q3 2025 Earnings Call Highlights: Record Highs in EBITDA and ... (GuruFocus.com)
Nov-05-25 08:30PM	Resideo Technologies (REZI) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:40PM	Resideo Technologies (REZI) Beats Q3 Earnings Estimates (Zacks)
06:36PM	Resideo Technologies: Q3 Earnings Snapshot (Associated Press Finance)
05:29PM	Resideo (NYSE:REZI) Misses Q3 Revenue Estimates, Stock Drops 19.6% (StockStory)
04:05PM	Resideo Announces Third Quarter 2025 Financial Results (PR Newswire)
Nov-04-25 09:40AM	Is Resideo Technologies (REZI) Stock Outpacing Its Industrial Products Peers This Year? (Zacks)
Nov-03-25 10:13PM	Resideo (REZI) Q3 Earnings: What To Expect (StockStory)
Oct-30-25 07:50AM	Xerox Holdings Corporation (XRX) Q3 Earnings Top Estimates (Zacks)
Oct-24-25 12:27PM	Resideo Technologies (REZI) Propelled on Strong Demand and Increased Guidance (Insider Monkey)
Oct-22-25 04:05PM	Resideo To Participate at Upcoming Investor Conferences (PR Newswire)
Oct-16-25 09:40AM	Is Resideo Technologies (REZI) Outperforming Other Industrial Products Stocks This Year? (Zacks)
Oct-15-25 05:06PM	Resideo To Release Third Quarter 2025 Financial Results on November 5, 2025 (PR Newswire)
Oct-13-25 09:41AM	Are Options Traders Betting on a Big Move in Resideo Technologies Stock? (Zacks)
Oct-03-25 06:03AM	Jim Cramer on Resideo Technologies: "It's Kind of Played Out" (Insider Monkey)
Sep-29-25 12:35AM	3 Hyped Up Stocks We Approach with Caution (StockStory)
Sep-25-25 11:31PM	Building Materials Stocks Q2 In Review: Resideo (NYSE:REZI) Vs Peers (StockStory)
Sep-24-25 09:40AM	Are Industrial Products Stocks Lagging Mitsui & Co. (MITSY) This Year? (Zacks)
Sep-18-25 11:26PM	Jim Cramer on Resideo Technologies: "Precisely the Kind of Stock That You Should be Buying" (Insider Monkey)
07:05PM	Resideo, MYR Group, Mercury Systems, Tutor Perini, and Helios Shares Are Soaring, What You Need To Know (StockStory)
Sep-16-25 02:02PM	Resideo Technologies: Institutional Activity Signals 30% Upside (MarketBeat)
Sep-12-25 04:00PM	Why Resideo (REZI) Stock Is Trading Up Today (StockStory)
Sep-11-25 08:53PM	Lightning Round: Canadian National is way too cheap, says Jim Cramer (CNBC TV)
Sep-02-25 05:46PM	Dueling Insider Moves: Heavy Buying Here, Big Selling There (MarketBeat)
Aug-22-25 05:16PM	Rapid7, Residio Tech, and 4 More Stocks See Action From Activist Investors (Barrons.com) +5.89%
Aug-14-25 05:15PM	Resideo, THOR Industries, JELD-WEN, Helios, and Luxfer Shares Are Falling, What You Need To Know (StockStory)
Aug-13-25 04:05PM	Resideo Announces Completion of Transaction with Honeywell To Accelerate Payment of All Potential Monetary Obligations Under Indemnification and Reimbursement Agreement (PR Newswire)
Aug-12-25 11:41PM	The Top 5 Analyst Questions From Resideo's Q2 Earnings Call (StockStory) +13.87%
11:40PM	REZI Q2 Deep Dive: Product Demand, Tariff Mitigation, and ADI Spin-Off Shape Results (StockStory)
03:46PM	Why Resideo (REZI) Stock Is Trading Up Today (StockStory)
02:07PM	Resideo Technologies Pops As Honeywell Indemnity Buyout Boosts Growth Story (Benzinga)
12:03AM	3 Reasons to Sell REZI and 1 Stock to Buy Instead (StockStory)
Aug-07-25 04:05PM	Resideo To Participate at Upcoming Investor Conferences (PR Newswire) -5.71%
Aug-06-25 01:20PM	Why Is Resideo (REZI) Stock Soaring Today (StockStory) +8.81%
03:35AM	Resideo Technologies Inc (REZI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Aug-05-25 05:42PM	Resideo (NYSE:REZI) Reports Upbeat Q2, Stock Soars (StockStory)
05:30PM	Resideo Technologies (REZI) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:35PM	Resideo Technologies: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Resideo Announces Record Second Quarter 2025 Financial Results; Raises 2025 Outlook; Initiates Third Quarter 2025 Outlook (PR Newswire)
Aug-03-25 11:07PM	Earnings To Watch: Resideo (REZI) Reports Q2 Results Tomorrow (StockStory)

Resideo Technologies, Inc. engages in the manufacture and development of technology-driven products and solutions that allow homeowners and businesses to stay connected and in control of their comfort, security, energy use, and smart living. It operates through the Products and Solutions, and ADI Global Distribution segments. The Products and Solutions segment offers temperature and humidity control, thermal water and air solutions, as well as security panels, sensors, peripherals, communications devices, video cameras, other home-related lifestyle convenience solutions, cloud infrastructure, installation, and maintenance tools, and related software. The ADI Global Distribution segment provides low-voltage security products including security and life safety, access control and video products and participates significantly in the broader related markets of smart home, power, audio, ProAV, networking, communications, wire and cable, and data communications. The company was founded on April 24, 2018 and is headquartered in Scottsdale, AZ.

PresidentMr. Thomas A. Surran

AdvisorMr. Jay L. Geldmacher

Executive VP & COO of ADI GlobalMs. Allie Copeland

Executive VP & Chief Merchandising Officer of ADI GlobalMr. Marco Cardazzi

President & CEO of ADI Global DistributionMr. Robert B. Aarnes

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mehta Amit Ashvin	SVP, Strategy & Business Ops	Aug 17 '26	Buy	20.68	10,928	225,999	57,362	Aug 18 07:33 AM
ROBERT AARNES	Officer	Aug 17 '26	Proposed Sale	21.27	47,000	999,742		Aug 17 04:24 PM
Foster Joshua Peter	SVP, GC & Corp Sec	Aug 14 '26	Buy	20.58	15,317	315,224	183,509	Aug 17 10:22 AM
SURRAN THOMAS A	President and CEO	Aug 14 '26	Buy	20.46	15,000	306,900	338,573	Aug 17 07:21 AM
Lane Jeannine J	EVP, GC and Corp Sec	Dec 10 '25	Option Exercise	10.27	76,109	781,639	231,667	Dec 12 05:30 PM
Kelly Stephen Montgomery	EVP, Chief HR Officer	Dec 10 '25	Option Exercise	10.27	81,818	840,271	315,614	Dec 12 05:30 PM
CD&R Channel Holdings II, L.P.	10% Owner	Nov 13 '25	Buy	31.82	566,758	18,034,557	14,960,492	Nov 13 08:52 PM
CD&R Channel Holdings II, L.P.	10% Owner	Nov 12 '25	Buy	32.02	400,000	12,807,960	14,393,734	Nov 13 08:52 PM
CD&R Channel Holdings II, L.P.	10% Owner	Nov 11 '25	Buy	30.54	390,000	11,912,082	13,993,734	Nov 13 08:52 PM
CD&R Channel Holdings II, L.P.	10% Owner	Nov 10 '25	Buy	30.69	333,000	10,219,837	13,603,734	Nov 13 08:52 PM
TEICH ANDREW C	Director	Nov 10 '25	Buy	30.68	8,149	249,976	340,621	Nov 12 06:00 AM
CD&R Channel Holdings II, L.P.	10% Owner	Sep 03 '25	Buy	33.63	228,573	7,688,030	13,270,734	Sep 04 06:58 PM
CD&R Channel Holdings II, L.P.	10% Owner	Sep 02 '25	Buy	33.55	180,000	6,038,118	13,042,161	Sep 04 06:58 PM
TEICH ANDREW C	Director	Aug 29 '25	Buy	34.01	29,460	1,001,876	332,472	Sep 03 04:38 PM
Richardson Nina	Director	Aug 26 '25	Sale	34.55	3,333	115,142	60,675	Aug 28 04:52 PM
CD&R Channel Holdings II, L.P.	10% Owner	Aug 22 '25	Buy	33.41	34,626	1,156,814	12,849,834	Aug 26 07:42 PM
CD&R Channel Holdings II, L.P.	10% Owner	Aug 25 '25	Buy	33.95	12,327	418,526	12,862,161	Aug 26 07:42 PM
NINA LOUISE RICHARDSON	Director	Aug 26 '25	Proposed Sale	34.55	3,333	115,142		Aug 26 03:57 PM
CD&R Channel Holdings II, L.P.	10% Owner	Aug 20 '25	Buy	31.94	297,000	9,485,438	12,565,208	Aug 21 07:47 PM
CD&R Channel Holdings II, L.P.	10% Owner	Aug 21 '25	Buy	32.16	250,000	8,040,900	12,815,208	Aug 21 07:47 PM

NTHI NeOnc Technologies Holdings Inc daily Stock Chart

Peers: AARD BMEA CNTB GNLX KZIA SPRO VRCA GALT IMUX AGEN

| Held by: VTI VXF IWC BUSM

Index	-
Market Cap	144.21M
Enterprise Value	142.57M
Income	-47.20M
Sales	0.00M
Book/sh	-0.75
Cash/sh	0.08
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	5
IPO	Mar 26, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	73.20
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.14
Current Ratio	0.14
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-2.12
EPS next Y	-1.03
EPS next Q	-0.23
EPS this Y	63.28%
EPS next Y	12.55%
EPS next 5Y	31.06%
EPS past 3/5Y	-176.88% -109.20%
Sales past 3/5Y	25.98% -
EPS Y/Y TTM	18.94%
Sales Y/Y TTM	-100.00%
EPS Q/Q	-93.43%
Sales Q/Q	-
Earnings	Aug 10 BMO
EPS/Sales Surpr.	-397.00% -

Insider Own	92.05%
Insider Trans	0.60%
Inst Own	12.17%
Inst Trans	32.75%
ROA	-1148.42%
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	45.17%
SMA50	34.25%
SMA200	-18.94%
Trades

Shs Outstand	24.85M
Shs Float	2.06M
Short Float	30.00%
Short Ratio	4.57
Short Interest	0.62M
52W High	12.99 -57.20%
52W Low	3.01 85.02%
Volatility	29.76% 13.27%
ATR (14)	0.53
RSI (14)	69.45
Beta	0.74
Rel Volume	0.15
Avg Volume	135.25K
Volume	1,029

Perf Week	60.69%
Perf Month	64.99%
Perf Quarter	1.46%
Perf Half Y	-38.08%
Perf YTD	-32.77%
Perf Year	6.92%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	16.00
Prev Close	5.53
Price	5.56
Change %	0.54%

Date	Action	Analyst	Rating Change	Price Target Change
May-19-26	Initiated	Alliance Global Partners	Buy	$13
May-18-26	Initiated	Maxim Group	Buy	$20
Apr-24-26	Initiated	BTIG Research	Buy	$15

Aug-18-26 10:18AM	NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't (GlobeNewswire) +12.63%
Aug-17-26 01:31PM	NeOnc Technologies Holdings Inc (NTHI) (Q2 2026) Earnings Call Highlights: First Annual Meeting ... (GuruFocus.com) +16.35%
08:45AM	NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results (GlobeNewswire)
Aug-13-26 04:18PM	Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26 (Newsfile) -7.23% +31.46%
02:31PM	The Nose Knows: Why NeOnc's Patent Portfolio Could Make NTHI More Than a One-Drug Biotech (GlobeNewswire)
09:39AM	Loading…
Aug-12-26 09:39AM	NeOnc Technologies shares jump after positive Phase 2a glioma results (InvestorsHub) -20.46%
09:38AM	Targeting The Mutant: NTHI's NEO100 Data Could Open a New Front in the Fight Against Brain Cancer (GlobeNewswire)
09:25AM	NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x (Newsfile)
08:00AM	NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma (GlobeNewswire)
Aug-11-26 08:44AM	NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence (Newsfile Corp.) +24.29%
Aug-10-26 10:34AM	NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears (GlobeNewswire)
09:00AM	NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout (GlobeNewswire)
08:30AM	NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma (GlobeNewswire)
Jul-27-26 09:00AM	NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors (GlobeNewswire)
Jul-15-26 09:00AM	NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition (GlobeNewswire)
08:45AM	Loading…
Jun-24-26 08:45AM	NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum (GlobeNewswire)
Jun-23-26 09:00AM	NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone (GlobeNewswire)
Jun-22-26 08:45AM	WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy (Newsfile)
Jun-16-26 01:49PM	Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND (GlobeNewswire) +14.86%
09:00AM	NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development (GlobeNewswire)
Jun-15-26 08:35AM	WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates (Newsfile) -5.05%
Jun-09-26 08:45AM	The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade (Newsfile Corp.)
May-29-26 09:05AM	The Next Great AI Revolution May Be Drug Delivery (GlobeNewswire)
May-19-26 10:28AM	NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones (GlobeNewswire)
May-18-26 09:00AM	NeOnc Provides Business Update and Reports Q1 2026 Financial Results (GlobeNewswire)
May-07-26 08:45AM	Biotech's Next Wave May Already be in Motion (GlobeNewswire) +22.22%
May-05-26 09:00AM	NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts (GlobeNewswire) +20.53%
Apr-14-26 09:00AM	NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results (GlobeNewswire)
Apr-01-26 09:00AM	NeOnc Provides Business Update and Reports Q4 2025 Financial Results (GlobeNewswire) -13.12%
Mar-13-26 09:00AM	NeOnc Technologies Appoints David Choi as Chief Accounting Officer (GlobeNewswire)
08:52AM	Loading…
Mar-12-26 08:52AM	Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) (Newsfile)
Mar-04-26 08:00AM	NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET (GlobeNewswire)
Feb-27-26 09:00AM	NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity (GlobeNewswire)
Jan-30-26 09:00AM	NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management (GlobeNewswire) +5.94%
Jan-09-26 07:32PM	Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) (Newsfile)
Dec-15-25 09:00AM	NeOnc Technologies Reports Updated Clinical Results (GlobeNewswire)
Dec-01-25 09:00AM	NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors (GlobeNewswire)
Nov-14-25 04:01PM	NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update (GlobeNewswire) -12.33%
Nov-13-25 09:00AM	NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High-Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026) (GlobeNewswire) -24.09%
Nov-12-25 08:00AM	NeOnc Technologies Reports Updated Clinical Results (GlobeNewswire)
Nov-07-25 09:00AM	NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program (GlobeNewswire)
Nov-04-25 09:00AM	NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth (GlobeNewswire)
Oct-28-25 09:00AM	His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment (GlobeNewswire) +6.92%
Oct-09-25 09:00AM	NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42's IROS and Expands Board of Directors (GlobeNewswire)
Oct-06-25 09:00AM	NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals (GlobeNewswire)
Oct-02-25 09:00AM	NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board (GlobeNewswire) +15.40%
Oct-01-25 09:00AM	NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health's Perlmutter Cancer Center, to Its Scientific Advisory Board (GlobeNewswire) +8.70%
Sep-29-25 09:00AM	NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board (GlobeNewswire) -11.39%
Sep-22-25 09:00AM	NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on "Health Uncensored with Dr. Drew" on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT (GlobeNewswire)
Sep-10-25 09:00AM	NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 - A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer (GlobeNewswire) +17.10%
Aug-25-25 09:00AM	NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board (GlobeNewswire)
Aug-19-25 09:00AM	NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update (GlobeNewswire)
Aug-11-25 09:00AM	NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation (GlobeNewswire) +6.68%
Aug-07-25 09:00AM	NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia (GlobeNewswire)
Aug-04-25 09:00AM	NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer (GlobeNewswire)
Jul-30-25 09:00AM	NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors (GlobeNewswire)
Jul-29-25 09:00AM	NeOnc Technologies Signs Definitive Agreement for $50 Million Strategic Partnership with Quazar Investment (GlobeNewswire) -7.76%
Jul-28-25 09:00AM	NeOnc Technologies to Participate at the BTIG Virtual Biotechnology Conference (GlobeNewswire) +6.08%
Jul-23-25 10:53AM	CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc. (GlobeNewswire)
09:00AM	NeOnc Technologies' Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks - Today at 11:00 a.m. ET (GlobeNewswire)
Jul-22-25 09:00AM	NeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment (GlobeNewswire)
Jul-10-25 09:00AM	NeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment (GlobeNewswire) -18.05%
Jul-09-25 09:00AM	NeOnc Technologies Holdings, Inc. Joins Russell Microcap Index (GlobeNewswire)
Jul-08-25 09:00AM	NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform (GlobeNewswire)
Jun-06-25 09:00AM	NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs (GlobeNewswire)
Apr-15-25 08:05AM	NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets (GlobeNewswire)
Apr-14-25 08:05AM	NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September (GlobeNewswire) -12.06%
Apr-10-25 08:05AM	NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President (GlobeNewswire) -10.00%
Apr-08-25 04:05PM	NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy (GlobeNewswire)
Mar-31-25 08:05AM	NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas (GlobeNewswire) -19.27%
Mar-28-25 11:15PM	U.S. IPO Weekly Recap: CoreWeave Fails To Impress In Downsized IPO, As More Names Join The Pipeline (Seeking Alpha) +37.92%
Mar-27-25 08:05AM	NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments (GlobeNewswire)

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

PresidentMr. Amir Farrokh Heshmatpour

Ph.D.Dr. Thomas C. Chen M.D.

Chief Financial OfficerMr. Keithly A. Garnett

Chief Clinical OfficerDr. Josh Neman-Ebrahim Ph.D.

Chief Accounting OfficerMr. David Choi Jr.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CHEN THOMAS C	CEO	Aug 14 '26	Buy	3.85	33,787	130,002	581,059	Aug 18 04:13 PM
CHEN THOMAS C	CEO	Aug 17 '26	Buy	4.04	2,472	9,998	583,531	Aug 18 04:13 PM
Heshmatpour Amir F	CEO, President	Aug 18 '26	Buy	5.54	9,000	49,860	3,096,000	Aug 18 02:30 PM
Heshmatpour Amir F	CEO, President	Aug 14 '26	Buy	3.79	12,000	45,460	3,084,000	Aug 17 06:49 PM
Heshmatpour Amir F	CEO, President	Aug 17 '26	Buy	4.37	3,000	13,120	3,087,000	Aug 17 06:49 PM
Heshmatpour Amir F	President	May 01 '26	Buy	4.16	10,000	41,592	3,072,000	May 04 02:08 PM
Heshmatpour Amir F	President	Apr 28 '26	Buy	4.52	10,000	45,180	3,062,000	Apr 28 06:00 PM
Neman-Ebrahim Yousha	Chief Clinical Officer	Apr 23 '26	Buy	4.88	500	2,440	134,760	Apr 24 06:10 PM
Heshmatpour Amir F	President	Apr 23 '26	Buy	4.90	10,000	49,000	3,052,000	Apr 23 09:34 PM
SUH, DAVID JR.	Chief Accounting Officer	Apr 09 '26	Buy	5.00	200	1,000	111,866	Apr 13 06:15 PM
Heshmatpour Amir F	President	Apr 10 '26	Buy	4.89	10,000	48,950	3,042,000	Apr 10 03:29 PM
Heshmatpour Amir F	President	Apr 08 '26	Buy	5.61	10,000	56,050	3,027,000	Apr 09 02:43 PM
Heshmatpour Amir F	President	Apr 09 '26	Buy	5.19	5,000	25,950	3,032,000	Apr 09 02:43 PM
Heshmatpour Amir F	President	Apr 02 '26	Buy	6.09	20,000	121,798	3,012,000	Apr 06 08:55 PM
Heshmatpour Amir F	President	Apr 06 '26	Buy	6.32	5,000	31,600	3,017,000	Apr 06 08:55 PM
Heshmatpour Amir F	President	Nov 21 '25	Buy	6.07	24,000	145,600	2,986,000	Nov 24 09:10 PM
Heshmatpour Amir F	President	Nov 24 '25	Buy	6.51	6,000	39,060	2,992,000	Nov 24 09:10 PM
Neman-Ebrahim Yousha	Chief Clinical Officer	Nov 20 '25	Buy	6.69	1,100	7,359	134,260	Nov 24 05:46 PM

VRCA Verrica Pharmaceuticals Inc daily Stock Chart

Peers: CNTB KZIA SPRO AGEN GALT IMUX MOLN HURA ORMP PLX

| Held by: VTI VXF IWC DFAS DFMC DCOR DFAC AVTM

Index	-
Market Cap	80.40M
Enterprise Value	71.01M
Income	-31.18M
Sales	30.32M
Book/sh	0.25
Cash/sh	0.65
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	76
IPO	Jun 15, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	2.65
P/B	18.67
P/C	7.18
P/FCF	-
EV/EBITDA	-
EV/Sales	2.34
Quick Ratio	1.21
Current Ratio	1.33
Debt/Eq	0.42
LT Debt/Eq	0.20
Option/Short	No / Yes

EPS (ttm)	-1.67
EPS next Y	-1.45
EPS next Q	-0.49
EPS this Y	-20.68%
EPS next Y	28.48%
EPS next 5Y	4.14%
EPS past 3/5Y	38.35% 37.12%
Sales past 3/5Y	57.93% -
EPS Y/Y TTM	79.84%
Sales Y/Y TTM	106.21%
EPS Q/Q	-2971.63%
Sales Q/Q	-53.85%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	-60.00% 2.24%

Insider Own	48.75%
Insider Trans	0.51%
Inst Own	26.57%
Inst Trans	-5.79%
ROA	-83.02%
ROE	-240.35%
ROIC	-604.20%
Gross Margin	85.89%
Oper. Margin	-87.18%
Profit Margin	-102.84%
SMA20	-10.01%
SMA50	-17.31%
SMA200	-23.99%
Trades

Shs Outstand	17.18M
Shs Float	8.80M
Short Float	3.27%
Short Ratio	6.78
Short Interest	0.29M
52W High	9.82 -52.35%
52W Low	3.28 42.68%
Volatility	7.54% 8.27%
ATR (14)	0.44
RSI (14)	34.73
Beta	1.47
Rel Volume	0.00
Avg Volume	42.46K
Volume	0

Perf Week	-10.34%
Perf Month	-14.75%
Perf Quarter	-20.27%
Perf Half Y	-15.06%
Perf YTD	-43.68%
Perf Year	-23.96%
Perf 3Y	-89.58%
Perf 5Y	-95.40%
Perf 10Y	-
Recom	1.33
Target Price	14.80
Prev Close	4.68
Price	4.68
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-26-26	Resumed	H.C. Wainwright	Buy	$12
Nov-06-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jul-25-23	Upgrade	Needham	Hold → Buy	$10
Mar-22-23	Initiated	Jefferies	Buy	$10
Feb-13-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$4 → $11
May-25-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$16 → $4
May-14-21	Initiated	RBC Capital Mkts	Outperform	$19
Dec-24-20	Reiterated	H.C. Wainwright	Buy	$18 → $21
Jul-15-20	Downgrade	BofA Securities	Buy → Neutral
Jun-30-20	Reiterated	H.C. Wainwright	Buy	$24 → $18
Jun-24-20	Initiated	Northland Capital	Outperform	$21
Mar-24-20	Initiated	Needham	Buy	$20
Feb-21-19	Initiated	H.C. Wainwright	Buy	$20

Show Previous Ratings

Aug-06-26 04:05PM	Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results (GlobeNewswire) -5.22%
04:01PM	Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital (GlobeNewswire)
Jul-30-26 08:00AM	Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 (GlobeNewswire)
Jul-21-26 08:00AM	Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH for the Treatment of Molluscum Contagiosum in Israel (GlobeNewswire)
Jun-22-26 08:05AM	Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH (VP-102) for the Treatment of Common Warts (GlobeNewswire)
08:05AM	Loading…
May-28-26 08:05AM	Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-13-26 08:30AM	Verrica Pharmaceuticals Inc. Q1 2026 Earnings Call Summary (Moby)
08:00AM	Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire)
01:01AM	Verrica Pharmaceuticals Inc (VRCA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-12-26 04:01PM	Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results (GlobeNewswire)
May-06-26 08:35AM	NanoViricides Measles Treatment Granted Orphan Drug Designation by FDA (Exec Edge) +17.74%
May-05-26 04:05PM	Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting (GlobeNewswire) +12.58%
08:00AM	Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026 (GlobeNewswire)
Apr-09-26 04:05PM	Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting (GlobeNewswire) -12.35%
Apr-06-26 08:00AM	Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire) +9.32%
03:01PM	Loading…
Mar-11-26 03:01PM	Verrica Pharmaceuticals Inc (VRCA) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
08:00AM	Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-05-26 08:00AM	Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026 (GlobeNewswire)
Feb-23-26 08:00AM	Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-12-26 08:00AM	Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer (GlobeNewswire)
Feb-09-26 08:00AM	Verrica Pharmaceuticals Announces Launch of YCANTH for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical (GlobeNewswire)
Feb-02-26 12:00PM	Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why (Zacks) +5.97%
05:59AM	New Strong Buy Stocks for February 2nd (Zacks)
Jan-12-26 09:55AM	How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11% (Zacks)
Jan-07-26 08:00AM	Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH (VP-102) for the Treatment of Common Warts (GlobeNewswire)
Nov-24-25 08:00AM	Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway (GlobeNewswire) +12.11%
Nov-17-25 04:00PM	Verrica Pharmaceuticals Inc (VRCA) Q3 2025 Earnings Call Highlights: Revenue Surge and ... (GuruFocus.com) -5.09%
Nov-14-25 04:05PM	Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-10-25 08:00AM	Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting (GlobeNewswire) +11.85%
Oct-24-25 11:00AM	Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
04:05PM	Loading…
Oct-20-25 04:05PM	Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH in the European Union (GlobeNewswire) +7.95% -9.82%
Oct-07-25 04:05PM	Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Sep-19-25 08:00AM	Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH (TO-208) in Japan for the Treatment of Molluscum Contagiosum (GlobeNewswire) +8.66%
Sep-02-25 07:00AM	Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-13-25 03:12AM	Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Aug-12-25 05:20PM	Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:01PM	Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-11-25 09:42AM	Verrica Pharmaceuticals Inc (VRCA) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.51%
Aug-06-25 05:10PM	Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +9.20%
07:00AM	Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025 (GlobeNewswire)
Jul-09-25 07:00AM	Verrica Pharmaceuticals Reports Strong Growth in YCANTH Dispensed Applicator Units in 2Q 2025 (GlobeNewswire)
Jul-01-25 07:00AM	Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH for the Treatment of Common Warts (GlobeNewswire) +13.37%
May-28-25 08:00AM	Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York (GlobeNewswire) -5.78%
May-14-25 08:10AM	Q1 2025 Verrica Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
03:16AM	Verrica Pharmaceuticals Inc (VRCA) Q1 2025 Earnings Call Highlights: Strong YCANTH Demand and ... (GuruFocus.com)
May-13-25 05:25PM	Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +8.63%
04:05PM	Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results (GlobeNewswire)
May-12-25 05:15PM	Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +15.07%
09:52AM	Earnings To Watch: Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2025 Result (GuruFocus.com)
May-08-25 05:50PM	4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +5.97%
May-07-25 08:00AM	Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025 (GlobeNewswire) -9.20%
May-02-25 07:10AM	Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates (Zacks)
Apr-30-25 08:00AM	Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York (GlobeNewswire)
Apr-07-25 08:00AM	Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH Dispensed Applicator Units in First Quarter 2025 (GlobeNewswire) +21.75%
Apr-02-25 04:05PM	Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors (GlobeNewswire)
Apr-01-25 09:55AM	Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Mar-31-25 08:00AM	Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-26-25 07:00AM	Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer (GlobeNewswire) -6.75%
Mar-12-25 01:48PM	Q4 2024 Verrica Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -7.56%
03:08AM	Verrica Pharmaceuticals Inc (VRCA) Q4 2024 Earnings Call Highlights: Revenue Growth and ... (GuruFocus.com)
Mar-11-25 05:25PM	Verrica Pharmaceuticals Inc. (VRCA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-03-25 07:00AM	Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025 (GlobeNewswire)
Feb-27-25 10:00AM	Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) -16.89%
Feb-25-25 04:05PM	Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston (GlobeNewswire)
Jan-21-25 07:00AM	Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference (GlobeNewswire) +5.12%
Dec-20-24 07:00AM	Verrica Provides Business and Operational Update (GlobeNewswire)
Dec-09-24 04:15PM	Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.94% -7.84%
Dec-06-24 08:00AM	Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan (GlobeNewswire)
Nov-21-24 07:30AM	Verrica Announces Pricing of $42.0 Million Public Offering (GlobeNewswire) +11.56%
Nov-20-24 04:05PM	Verrica Announces Proposed Public Offering (GlobeNewswire)
Nov-04-24 04:05PM	Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition (GlobeNewswire) -6.54% -44.23%
Oct-24-24 07:00AM	Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference (GlobeNewswire)
Oct-09-24 06:21PM	Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ... (GuruFocus.com)
Oct-02-24 07:30AM	Verrica Pharmaceuticals Announces Restructuring of Commercial Organization (GlobeNewswire) -18.98%
Sep-29-24 08:02AM	Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now (Insider Monkey)
Sep-25-24 11:27AM	Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers? (Insider Monkey) -5.68%
Sep-20-24 05:21AM	Notice to Long-Term Shareholders of Verrica Pharmaceuticals, Inc. (VRCA) (Newsfile) -6.70%
Sep-04-24 07:30AM	Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York (GlobeNewswire) +5.50%
Aug-15-24 07:32AM	Verrica stock drops after half patients tumours gone in skin cancer trial (Clinical Trials Arena) -6.73%
Aug-14-24 09:52AM	Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday? (Benzinga) -40.80%
08:55AM	Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:45AM	Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results (GlobeNewswire)
07:30AM	Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Patients with Basal Cell Carcinoma (GlobeNewswire)
Aug-06-24 07:30AM	Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024 (GlobeNewswire) -5.45%
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jul-01-24 07:30AM	Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc. (GlobeNewswire) +9.05%
May-30-24 04:30PM	Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York (GlobeNewswire)
May-15-24 09:11AM	Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth (MT Newswires)
07:30AM	Verrica Pharmaceuticals Announces Amendment to Company's Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH for the Treatment of Common Warts (GlobeNewswire)
May-14-24 09:28AM	HC Wainwright Adjusts Price Target on Verrica Pharmaceuticals to $14 From $13, Maintains Buy Rating (MT Newswires)
08:50AM	Needham Adjusts Price Target on Verrica Pharmaceuticals to $16 From $8, Keeps Buy Rating (MT Newswires)
03:01AM	Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-13-24 11:53AM	VRCA Stock Earnings: Verrica Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +19.50%
09:12AM	Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review (GuruFocus.com)
08:40AM	Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 07:30AM	Verrica Pharmaceuticals to Present at Upcoming Investor Conferences (GlobeNewswire)
May-08-24 07:30AM	Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
May-06-24 06:35AM	Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last? (Zacks)

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Ph.D.Dr. Jayson M. Rieger M.B.A.

Interim Chief Financial OfficerMr. John J. Kirby CPA

Chief Medical OfficerDr. Noah L. Rosenberg M.D.

COOMr. David Zawitz

Executive Vice President of Technical OperationsMr. Eugene Scavola

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zawitz David	Chief Operating Officer	Aug 17 '26	Buy	4.98	6,000	29,880	27,000	Aug 18 05:00 PM
Rieger Jayson	CEO and President	Aug 14 '26	Buy	5.06	20,000	101,200	202,593	Aug 18 05:00 PM
Rieger Jayson	CEO and President	Aug 17 '26	Buy	4.91	5,000	24,550	207,593	Aug 18 05:00 PM
Rosenberg Noah L.	CMO	Aug 17 '26	Buy	4.91	4,200	20,622	6,557	Aug 18 05:00 PM
Rosenberg Noah L.	CMO	Aug 18 '26	Buy	4.92	2,030	9,988	8,587	Aug 18 05:00 PM
Kirby John J.	Interim CFO	Aug 18 '26	Buy	4.93	5,000	24,650	23,962	Aug 18 05:00 PM
Rosenberg Noah L.	CMO	Nov 25 '25	Buy	4.24	2,357	10,000	2,357	Nov 25 07:00 PM
Kirby John J.	Interim CFO	Nov 25 '25	Buy	4.24	3,536	15,001	8,962	Nov 25 07:00 PM
Zawitz David	Chief Operating Officer	Nov 25 '25	Buy	4.24	10,000	42,425	21,000	Nov 25 07:00 PM
Rieger Jayson	CEO and President	Nov 25 '25	Buy	4.24	94,311	400,114	182,593	Nov 25 07:00 PM
Manning Paul B	Director	Nov 25 '25	Buy	4.24	2,750,762	11,670,108	3,348,372	Nov 25 07:00 PM
Manning Paul B	Director	Nov 25 '25	Buy	4.24	1,375,380	5,835,050	3,958,189	Nov 25 07:00 PM

Peers: CRH MLM VMC EXP JHX MAS CARR LII AOS CX

| Held by: VXF PAVE VAW IFRA ITOT SCHX JAVA PKB OAKM DFIV

Index	-
Market Cap	24.77B
Enterprise Value	31.12B
Income	1.21B
Sales	12.19B
Book/sh	23.40
Cash/sh	1.32
Dividend Est.	0.60 (1.35%)
Dividend TTM	0.11 (0.25%)
Dividend Ex-Date	Aug 18, 2026
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	19000
IPO	Jun 23, 2025

P/E	20.55
Forward P/E	14.99
PEG	0.89
P/S	2.03
P/B	1.91
P/C	33.98
P/FCF	18.75
EV/EBITDA	10.83
EV/Sales	2.55
Quick Ratio	0.73
Current Ratio	1.10
Debt/Eq	0.55
LT Debt/Eq	0.39
Option/Short	Yes / Yes

EPS (ttm)	2.18
EPS next Y	2.99
EPS next Q	1.10
EPS this Y	20.49%
EPS next Y	15.78%
EPS next 5Y	16.82%
EPS past 3/5Y	2.24% -
Sales past 3/5Y	3.28% -
EPS Y/Y TTM	1.61%
Sales Y/Y TTM	5.09%
EPS Q/Q	11.32%
Sales Q/Q	8.51%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	-7.76% 3.80%

Insider Own	10.91%
Insider Trans	0.26%
Inst Own	49.89%
Inst Trans	-1.13%
ROA	4.98%
ROE	9.53%
ROIC	6.72%
Gross Margin	25.02%
Oper. Margin	15.63%
Profit Margin	9.89%
SMA20	-7.38%
SMA50	-11.53%
SMA200	-16.21%
Trades

Shs Outstand	549.78M
Shs Float	493.15M
Short Float	1.63%
Short Ratio	2.40
Short Interest	8.02M
52W High	65.13 -31.30%
52W Low	44.30 1.02%
Volatility	2.07% 2.54%
ATR (14)	1.45
RSI (14)	35.79
Beta	0.05
Rel Volume	0.02
Avg Volume	3.34M
Volume	3,035

Perf Week	-3.26%
Perf Month	-7.87%
Perf Quarter	-7.11%
Perf Half Y	-28.88%
Perf YTD	-16.23%
Perf Year	-11.10%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.96
Target Price	57.65
Prev Close	44.63
Price	44.75
Change %	0.27%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-10-26	Downgrade	RBC Capital Mkts	Sector Perform → Underperform	$48
Jul-07-26	Downgrade	Truist	Buy → Hold	$48
May-01-26	Upgrade	Vertical Research	Hold → Buy	$70
Dec-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$60
Nov-14-25	Resumed	Stephens	Overweight
Sep-09-25	Initiated	Oppenheimer	Outperform	$62
Jul-15-25	Initiated	JP Morgan	Overweight	$57
Jul-10-25	Initiated	Bernstein	Outperform	$62
Jul-01-25	Initiated	Goldman	Neutral	$57
Jun-30-25	Initiated	Jefferies	Hold	$52.50
Jun-30-25	Initiated	Erste Group	Buy
Jun-30-25	Initiated	Berenberg	Buy	$64
Jun-26-25	Initiated	BofA Securities	Neutral	$56
Jun-24-25	Initiated	UBS	Neutral	$53
Jun-24-25	Initiated	Truist	Buy	$60
Jun-24-25	Initiated	RBC Capital Mkts	Outperform	$61
Jun-24-25	Initiated	Morgan Stanley	Overweight	$62

Show Previous Ratings

Aug-10-26 04:15PM	Amrize Files Form 10-Q for Second Quarter 2026 (Business Wire)
Aug-07-26 11:06PM	Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com) -8.94%
05:01PM	Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Amid Cost Headwinds (GuruFocus.com)
03:22AM	Amrize stock tumbles on Q2 profit miss, EBITDA guide cut (Investing.com)
Aug-06-26 04:50PM	Amrize Reports Second Quarter 2026 Results (Business Wire)
09:00AM	Loading…
Jul-20-26 09:00AM	Amrize to Acquire Rapid Redi-Mix in Dallas-Fort Worth (Business Wire)
Jul-16-26 09:00AM	Amrize Announces Date for Second Quarter 2026 Financial Results (Business Wire)
Jul-07-26 01:21PM	Amrize shares tumble as Truist downgrades on roofing pressures and cement pricing (Investing.com) -5.68%
Jun-19-26 10:30AM	Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada (Business Wire)
May-05-26 01:00AM	Amrize Launches $1 Billion Share Buyback Program (Business Wire)
May-01-26 03:01AM	Amrize Ltd (AMRZ) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges (GuruFocus.com)
Apr-29-26 04:15PM	Amrize Grows Revenue 4.7% in First Quarter and Reaffirms 2026 Guidance (Business Wire) -5.27%
Apr-21-26 04:15PM	Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting (Business Wire)
Apr-15-26 10:30AM	Amrize Expands 'Made in America' Label to Nine U.S. Cement Plants (Business Wire)
Mar-31-26 08:06PM	Is Amrize Ltd (AMRZ) Stock Outpacing Its Construction Peers This Year? (Quartz)
04:15PM	Loading…
04:15PM	Amrize Appoints Baris Oran as Chief Financial Officer (Business Wire)
Mar-12-26 04:15PM	Amrize Publishes Annual Report for Fiscal Year 2025 (Business Wire)
Mar-03-26 11:00AM	Amrize Launches EVERtect High-Performance Concrete Range at CONEXPO-CON/AGG 2026 (Business Wire)
Feb-22-26 02:31AM	Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating (Insider Monkey)
Feb-18-26 04:20PM	Amrize Closes Acquisition of PB Materials; Aggregates Leader in High-Growth West Texas (Business Wire) +10.99%
04:03PM	Amrize Ltd (AMRZ) Q4 2025 Earnings Call Highlights: Strategic Moves and Financial Resilience (GuruFocus.com)
01:44PM	Analyst Report: Amrize AG (Morningstar Research)
10:50AM	Amrize Q4 Earnings Call Highlights (MarketBeat)
Feb-17-26 07:30PM	Amrize Ltd (AMRZ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:15PM	Amrize Delivers Strong Free Cash Flow in 2025; Shareholder Return Plan Proposed (Business Wire)
Feb-11-26 09:05PM	Amrize Board of Directors Changes (Business Wire)
Jan-28-26 09:00AM	Amrize Announces Date for Fourth Quarter and Full-Year 2025 Financial Results (Business Wire)
Jan-20-26 08:36AM	Is the Options Market Predicting a Spike in Amrize Stock? (Zacks)
Jan-16-26 07:51AM	Amrize price target raised to $64 from $62 at Oppenheimer (TipRanks)
Jan-06-26 08:15PM	Amrize to Acquire PB Materials; Aggregates Leader in High-Growth West Texas (Business Wire)
07:40AM	Loading…
Dec-18-25 07:40AM	Who Actually Benefits From the $200 Billion Infrastructure Boom? We Compared 3 Stocks. (24/7 Wall St.)
Dec-16-25 10:00AM	Amrize Expands Production Capacity at Flagship U.S. Cement Plant (Business Wire)
Nov-13-25 11:00AM	Amrize Launches 'Made in America' Label for U.S. Builders (Business Wire)
Nov-07-25 06:02AM	Insiders Bet Big on These 2 Stocks Heres Why Analysts Think a Payoff Could Be Ahead (TipRanks)
Nov-03-25 07:28PM	Analyst Report: Amrize AG (Morningstar Research)
Oct-29-25 01:10PM	Analyst Report: Amrize AG (Morningstar Research)
Oct-28-25 07:00PM	Here's What Key Metrics Tell Us About Amrize Ltd (AMRZ) Q3 Earnings (Zacks)
04:15PM	Amrize Delivers Strong Third Quarter Revenue Growth and Free Cash Flow Generation (Business Wire)
09:20AM	Amrize Ltd (AMRZ) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-27-25 09:19AM	What To Expect From Amrize Ltd (AMRZ) Q3 2025 Earnings (GuruFocus.com)
Oct-23-25 12:04PM	Do Options Traders Know Something About Amrize Stock We Don't? (Zacks)
Oct-09-25 11:00AM	Amrize Announces Date for Third Quarter 2025 Financial Results (Business Wire)
08:51AM	America's Fading Stock Premium (The Wall Street Journal)
Sep-23-25 11:00AM	Amrize Partners with Chicago Architecture Biennial to Advance Building (Business Wire)
Sep-18-25 09:00AM	Amrize Launches Next-Generation Carrier to Further Strengthen Distribution Network for Growth (Business Wire)
Sep-16-25 04:59AM	New Strong Sell Stocks for September 16th (Zacks)
Sep-15-25 09:03AM	Amrize AG (AMRZ) Downplays TRC Capital Tender Offer (Insider Monkey)
Sep-11-25 02:15PM	Oppenheimer Initiates Coverage of Amrize (AMRZ) with Outperform Rating, Cites Growth Strategy, Strong Financials (Insider Monkey)
Sep-05-25 06:26AM	New Strong Sell Stocks for September 5th (Zacks)
Aug-29-25 06:29AM	New Strong Sell Stocks for August 29th (Zacks)
Aug-28-25 06:44PM	Amrize Recommends Shareholders Reject Mini-Tender Offer By TRC Capital Investment Corporation (Business Wire)
Aug-07-25 01:09PM	Analyst Report: Amrize AG (Morningstar Research) -6.72%
05:09AM	Amrize shares tumble 10% on big guidance miss, disappointing Q2 print (Investing.com)
Aug-06-25 04:15PM	Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength (Business Wire)
Jul-29-25 10:30AM	Here are Bronte Capital's Views on Amrize Ltd (AMRZ) (Insider Monkey)
Jul-21-25 02:00PM	Amrize Announces Date for Second Quarter 2025 Financial Results (Business Wire)
Jul-16-25 09:53AM	Amrize and Meta Partner on First-of-its-kind AI-Optimized Advanced Concrete Mix for Data Center in Minnesota (Business Wire)
Jul-03-25 11:36AM	Why Its Time to Buy This Rocks and Cement Spinoff Stock Youve Probably Never Heard Of (Barrons.com)
Jun-23-25 04:46PM	Amrize Stock Gains on First Trading Day (The Wall Street Journal)
04:35PM	Cement Firm Amrize Falls in Spinoff Debut as Holcim Jumps (Bloomberg)
08:55AM	NYSE Content Advisory: Pre-Market update + Amrize begins trading on the NYSE (PR Newswire)
12:47AM	Amrize Debuts as Independent, Publicly Traded Company (Business Wire)

Amrize Ltd. engages in selling building materials. It operates through the Building Materials and Building Envelope segments. The Building Materials segment offers cement and aggregates, as well as a variety of downstream products and solutions such as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment includes roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing and protective coatings, along with adhesives, tapes, and sealants that are critical to the application of roofing and wall systems. The company was founded on April 6, 2023 and is headquartered in Chicago, IL.

CEO & ChairmanMr. Jan Philipp Jenisch

Chief Legal Officer & Corporate SecretaryMs. Denise Rene Perry Singleton J.D.

President of Building MaterialsMr. Jaime Hill

President of Building EnvelopeMr. James J. Gosa

Chief Financial OfficerMr. Baris Oran

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Poletti Samuel Jonas	Chief Strategy & M&A Officer	Aug 17 '26	Buy	46.92	2,510	117,769	10,155	Aug 18 12:29 PM
Clark Stephen S	Chief People Officer	Aug 11 '26	Buy	47.31	5,260	248,851	10,637	Aug 13 11:46 AM
Brouwer Roald	Chief Technology Officer	Aug 11 '26	Buy	46.36	1,500	69,540	21,490	Aug 13 11:41 AM
Gross Mario	Chief Supply Chain Officer	Aug 11 '26	Buy	46.60	3,568	166,252	38,485	Aug 13 11:29 AM
Hill Jaime	President, Building Materials	Aug 11 '26	Buy	47.12	1,500	70,680	29,698	Aug 13 11:23 AM
Oran Baris	Chief Financial Officer	Aug 11 '26	Buy	47.38	3,000	142,140	3,000	Aug 13 11:10 AM
Oran Baris	Chief Financial Officer	Aug 12 '26	Buy	47.13	3,000	141,390	6,000	Aug 13 11:10 AM
Forrest Nollaig	Chief Mktg & Corp Affairs Off	May 22 '26	Buy	50.25	2,000	100,500	20,139	May 26 01:47 PM
Brouwer Roald	Chief Technology Officer	May 21 '26	Buy	49.84	1,500	74,760	19,757	May 21 12:36 PM
Gross Mario	Chief Supply Chain Officer	May 19 '26	Buy	49.17	2,800	137,676	33,747	May 21 12:31 PM
Gross Mario	Chief Supply Chain Officer	May 20 '26	Buy	48.63	1,200	58,356	34,747	May 21 12:31 PM
Jenisch Jan Philipp	Chairman & CEO	May 19 '26	Buy	49.28	16,001	788,571	1,741,000	May 20 10:26 AM
Jenisch Jan Philipp	Chairman & CEO	May 19 '26	Buy	49.96	3,000	149,880	515,000	May 20 10:26 AM
Jenisch Jan Philipp	Chairman & CEO	May 15 '26	Buy	49.67	21,417	1,063,731	1,724,999	May 18 04:33 PM
Jenisch Jan Philipp	Chairman & CEO	May 15 '26	Buy	49.12	7,000	343,840	512,000	May 18 04:33 PM
Clark Stephen S	Chief People Officer	May 05 '26	Buy	52.75	2	114	5,260	May 07 04:35 PM
Gross Mario	Chief Supply Chain Officer	Mar 13 '26	Buy	55.29	3,200	176,936	30,947	Mar 16 01:59 PM
Brouwer Roald	Chief Technology Officer	Mar 13 '26	Buy	54.88	2,000	109,760	18,257	Mar 16 01:53 PM
Hill Jaime	President, Building Materials	Mar 12 '26	Buy	56.90	1,000	56,900	28,000	Mar 12 02:02 PM
Johnston Ian A	Chief Financial Officer	Mar 10 '26	Buy	58.94	4,250	250,474	25,110	Mar 11 02:00 PM
Hill Jaime	President, Building Materials	Mar 11 '26	Buy	58.91	1,000	58,910	27,000	Mar 11 01:56 PM
Brouwer Roald	Chief Technology Officer	Mar 11 '26	Buy	58.72	3,000	176,160	16,257	Mar 11 01:49 PM
Hill Jaime	President, Building Materials	Mar 09 '26	Buy	56.34	3,184	179,387	26,000	Mar 10 01:06 PM
Jenisch Jan Philipp	Chairman & CEO	Mar 06 '26	Buy	58.05	60,000	3,483,000	1,703,582	Mar 09 01:31 PM
Johnston Ian A	Chief Financial Officer	Feb 19 '26	Buy	63.92	1,200	76,702	18,544	Feb 23 02:25 PM
Gangestad Nicholas C	Director	Nov 19 '25	Buy	47.34	2,000	94,680	4,958	Nov 20 02:32 PM
Hill Jaime	President, Building Materials	Nov 04 '25	Buy	50.69	4,000	202,740	18,101	Nov 06 01:38 PM
Brouwer Roald	Chief Technology Officer	Oct 31 '25	Buy	51.77	4,000	207,100	9,000	Nov 04 12:09 PM
Jenisch Jan Philipp	Chairman & CEO	Oct 30 '25	Buy	52.88	55,000	2,908,400	505,000	Oct 31 11:36 AM
Jenisch Jan Philipp	Chairman & CEO	Oct 30 '25	Buy	52.64	55,000	2,895,200	1,505,000	Oct 31 11:36 AM
Brouwer Roald	Chief Technology Officer	Aug 27 '25	Buy	51.88	2,000	103,760	5,000	Aug 27 11:21 AM
Hill Jaime	President, Building Materials	Aug 22 '25	Buy	49.59	500	24,792	14,101	Aug 25 04:54 PM

ELAN Elanco Animal Health Inc daily Stock Chart

Peers: ZTS NBIX IDXX JAZZ LH EXEL BMY RPRX CHWY WOOF

| Held by: VTI IJH VB VBR VXF XMMO MDY IJK DFAT SPMD

Index	-
Market Cap	11.86B
Enterprise Value	15.25B
Income	-199.00M
Sales	5.02B
Book/sh	13.19
Cash/sh	1.06
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	9900
IPO	Sep 20, 2018

P/E	-
Forward P/E	18.89
PEG	1.23
P/S	2.36
P/B	1.80
P/C	22.38
P/FCF	31.30
EV/EBITDA	14.87
EV/Sales	3.04
Quick Ratio	1.10
Current Ratio	2.05
Debt/Eq	0.59
LT Debt/Eq	0.58
Option/Short	Yes / Yes

EPS (ttm)	-0.40
EPS next Y	1.26
EPS next Q	0.20
EPS this Y	19.33%
EPS next Y	12.07%
EPS next 5Y	15.30%
EPS past 3/5Y	-43.04% 18.11%
Sales past 3/5Y	2.25% 7.57%
EPS Y/Y TTM	-145.71%
Sales Y/Y TTM	11.95%
EPS Q/Q	380.63%
Sales Q/Q	10.23%
Earnings	Aug 05 BMO
EPS/Sales Surpr.	26.30% 4.23%

Insider Own	1.01%
Insider Trans	0.66%
Inst Own	113.84%
Inst Trans	0.10%
ROA	-1.46%
ROE	-2.98%
ROIC	-1.91%
Gross Margin	44.28%
Oper. Margin	6.63%
Profit Margin	-3.96%
SMA20	-2.69%
SMA50	-3.16%
SMA200	0.65%
Trades

Shs Outstand	499.55M
Shs Float	494.59M
Short Float	7.28%
Short Ratio	5.59
Short Interest	36.00M
52W High	27.98 -15.13%
52W Low	17.11 38.78%
Volatility	3.03% 4.21%
ATR (14)	1.00
RSI (14)	46.68
Beta	1.67
Rel Volume	0.00
Avg Volume	6.44M
Volume	429

Perf Week	7.30%
Perf Month	-6.81%
Perf Quarter	19.93%
Perf Half Y	-4.18%
Perf YTD	4.93%
Perf Year	35.53%
Perf 3Y	104.35%
Perf 5Y	-24.62%
Perf 10Y	-
Recom	1.22
Target Price	31.46
Prev Close	23.64
Price	23.75
Change %	0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-15-26	Initiated	Citigroup	Buy	$30
Jan-22-26	Upgrade	Piper Sandler	Neutral → Overweight
Dec-09-25	Initiated	Barclays	Overweight	$30
Nov-21-25	Initiated	KeyBanc Capital Markets	Overweight	$27
Nov-19-25	Upgrade	Argus	Hold → Buy	$25
Oct-07-25	Upgrade	JP Morgan	Neutral → Overweight	$24
Jul-17-25	Upgrade	Leerink Partners	Market Perform → Outperform	$18
Jun-26-25	Upgrade	William Blair	Mkt Perform → Outperform
Dec-09-24	Initiated	UBS	Buy	$18
Dec-02-24	Initiated	Leerink Partners	Market Perform	$14
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $15
Jan-05-24	Upgrade	Stifel	Hold → Buy	$13 → $20
Dec-19-23	Initiated	Jefferies	Buy	$17
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$16
Dec-07-23	Initiated	Exane BNP Paribas	Outperform	$18
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight	$14
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$37 → $22
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral	$28 → $24
Jul-21-22	Downgrade	Goldman	Buy → Sell	$32 → $19
Jul-12-22	Initiated	Piper Sandler	Neutral	$22

Show Previous Ratings

Aug-07-26 02:20PM	Elanco's CLiK Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species (PR Newswire) -8.60%
Aug-06-26 05:33PM	Elanco CEO on Boosted Forecast, Surge in Tick Bites (Bloomberg) -7.70%
Aug-05-26 03:01PM	Elanco Animal Health Inc (ELAN) (Q2 2026) Earnings Call Highlights: Strong Innovation Drives 8% ... (GuruFocus.com)
06:27AM	Elanco Animal Health Reports Second Quarter 2026 Results (PR Newswire)
Jul-31-26 07:32AM	Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs (PR Newswire)
06:27AM	Loading…
Jul-22-26 06:27AM	Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard Plus (afoxolaner, moxidectin, and pyrantel chewable tablets) (PR Newswire)
Jul-08-26 08:00AM	Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement (PR Newswire)
Jun-18-26 07:26AM	Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health (PR Newswire)
Jun-15-26 08:47AM	Elanco Announces USDA Approval of TruCan Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs (PR Newswire)
Jun-04-26 01:47PM	Beef Supply Resilient, Screwworm or No, Elanco CEO Says (The Wall Street Journal)
10:23AM	Cattle Prices Are a Problem for Tyson and JBS Stock. Could New World Screwworm Make Things Worse? (Barrons.com)
06:26AM	Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm (PR Newswire)
Jun-03-26 07:26AM	New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience (PR Newswire)
May-18-26 07:27AM	Elanco Launches Befrena (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market (PR Newswire)
May-14-26 08:00AM	Elanco to Participate in Upcoming Investor Conferences (PR Newswire)
12:51PM	Loading…
May-06-26 12:51PM	Elanco Animal Health Incorporated Q1 2026 Earnings Call Summary (Moby) +13.88%
08:12AM	Elanco (ELAN) shares climb after strong quarterly results and higher full-year outlook (InvestorsHub)
06:27AM	Elanco Animal Health Reports First Quarter 2026 Results (PR Newswire)
Apr-27-26 06:23PM	Elanco's Negasunt Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock (PR Newswire)
Apr-16-26 08:00AM	Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement (PR Newswire)
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
Apr-13-26 04:08PM	Marriott Upgraded, Palantir Downgraded: Updated Rankings on Top Blue-Chip Stocks (InvestorPlace)
Apr-09-26 08:27AM	Elanco Launches Advantage Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* (PR Newswire)
Mar-23-26 01:38PM	Pet Services Jump 5.1% as Vet Visits Fall for 16th Straight Quarter (GuruFocus.com)
Mar-16-26 03:23PM	Tesla Upgraded, Super Micro Computer Downgraded: Updated Rankings on Top Blue-Chip Stocks (InvestorPlace)
Feb-26-26 09:56AM	Jim Cramer Highlights Elanco's "Comeback Story" (Insider Monkey)
Feb-24-26 04:22PM	Elanco Animal Health Q4 Earnings Call Highlights (MarketBeat) +6.59%
03:08PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
02:01PM	Elanco Animal Health Inc (ELAN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
12:32PM	Elanco Animal Health Incorporated Q4 2025 Earnings Call Summary (Moby)
11:25AM	Loading…
11:25AM	Why Is Elanco (ELAN) Stock Soaring Today (StockStory)
09:30AM	Elanco Animal Health (ELAN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:15AM	Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
06:38AM	Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales (StockStory)
06:27AM	Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results (PR Newswire)
Feb-23-26 10:57AM	Where is Elanco Animal Health Incorporated (ELAN) Headed According to the Street? (Insider Monkey)
Feb-22-26 10:06PM	What To Expect From Elanco's (ELAN) Q4 Earnings (StockStory)
Feb-19-26 09:15AM	Countdown to Elanco Animal Health (ELAN) Q4 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
08:00AM	Elanco to Participate in Upcoming Investor Conferences (PR Newswire)
Feb-13-26 09:24AM	Elanco Announces Updates to Board of Directors (PR Newswire)
Feb-10-26 06:41AM	Here's What the Street Thinks About Elanco Animal Health Incorporated (ELAN) (Insider Monkey)
Jan-30-26 11:56AM	Can Operational Execution Support DaVita's Q4 Performance? (Zacks)
Jan-28-26 07:50AM	Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health (ELAN) (Insider Monkey)
Jan-27-26 04:04PM	Gold and Silver Arent the Only Hot Commodities. Agricultural Stocks to Consider. (Barrons.com)
Jan-26-26 11:35PM	2 Profitable Stocks to Own for Decades and 1 Facing Headwinds (StockStory)
Jan-22-26 04:36PM	Stocks Settle Higher as Global Tensions Cool and the Economy Expands (Barchart)
08:00AM	Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement (PR Newswire)
06:00AM	Companies Move to Refinance Sooner: Better Off to Lock It In (The Wall Street Journal)
Jan-12-26 06:54PM	Elanco CEO: Gaining Market Share Via 'Major' Innovations (Bloomberg)
Jan-06-26 11:08PM	3 Reasons to Avoid ELAN and 1 Stock to Buy Instead (StockStory)
06:52PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
08:00AM	Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-25 02:00PM	Elanco Receives USDA Approval for Befrena (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis (PR Newswire)
Dec-21-25 10:07AM	Jim Cramer on Elanco Animal Health: "They Are Doing Everything Right" (Insider Monkey)
Dec-19-25 01:30AM	Elanco CEO Bites Off More Shares of Fast-Rising Stock (Barrons.com)
Dec-18-25 08:43AM	Elanco's Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs (PR Newswire)
Dec-16-25 02:05PM	Elanco (ELAN) Stock Is Up, What You Need To Know (StockStory)
09:40AM	Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year? (Zacks)
Dec-12-25 12:00PM	All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy (Zacks)
Dec-09-25 04:15PM	How Protein And Pets Drove Elanco Animal Health's Double-Digit Gain In 2025 (Investor's Business Daily) -5.81%
07:40AM	Elanco Investor Day Defines New Era as Sustainable Growth Company (PR Newswire)
Nov-24-25 07:00PM	Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know (StockStory)
Nov-21-25 01:35PM	Elanco's Credelio CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats (PR Newswire)
Nov-20-25 08:00AM	Elanco to Participate in the Upcoming Investor Conferences (PR Newswire)
Nov-14-25 09:03AM	Pet Healthcare Spending Is Soaring. These 5 Stocks Are Positioned to Clean Up (24/7 Wall St.)
Nov-13-25 08:00AM	Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health (PR Newswire)
Nov-12-25 12:35AM	5 Revealing Analyst Questions From Elanco's Q3 Earnings Call (StockStory)
Nov-11-25 08:46AM	Are Options Traders Betting on a Big Move in Elanco Animal Health Stock? (Zacks)
Nov-06-25 12:33AM	ELAN Q3 Deep Dive: Innovation Drives Growth, but Market Eyes Margin and Competition (StockStory)
Nov-05-25 07:26PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
03:12PM	Elanco Animal Health CEO: Seeing a willingness to spend, durability even in 'consumer tested' time (CNBC TV)
02:01PM	Elanco Animal Health Inc (ELAN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
09:30AM	Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics (Zacks)
07:35AM	Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:36AM	Elanco (NYSE:ELAN) Surprises With Q3 Sales (StockStory)
06:27AM	Elanco Animal Health Reports Third Quarter 2025 Results (PR Newswire)
Nov-03-25 10:19PM	Elanco (ELAN) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
04:28PM	How Idexx Laboratories Business Shook Off Bears And Hit A Record (Investor's Business Daily)
Oct-29-25 10:00AM	Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect (Zacks)
Oct-28-25 11:27AM	Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? (Zacks)
Oct-27-25 06:27AM	Elanco Announces Expansion of Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species (PR Newswire)
Oct-24-25 05:33PM	Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment (The Wall Street Journal)
04:55PM	Elanco's Credelio (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs (PR Newswire)
12:02AM	Elanco (ELAN): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Oct-23-25 11:40AM	ELAN vs. USPH: Which Stock Is the Better Value Option? (Zacks)
Oct-22-25 09:40AM	Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-20-25 02:03PM	West Pharmaceutical Services Stock Sees RS Rating Climb To 71 (Investor's Business Daily)
Oct-17-25 06:39PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
Oct-16-25 04:32PM	Elanco to Host Investor Day on December 9 (PR Newswire)
Oct-08-25 12:00PM	Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy? (Zacks)
Oct-07-25 11:31AM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
Oct-06-25 11:40AM	ELAN or USPH: Which Is the Better Value Stock Right Now? (Zacks)
05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
Oct-01-25 08:00AM	Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement (PR Newswire)
Sep-30-25 12:00PM	Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-24-25 12:01PM	Why Elanco (ELAN) Stock Is Up Today (StockStory)
Sep-23-25 07:10PM	Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up (Insider Monkey)
06:27AM	Elanco Announces FDA Approves Improved Zenrelia (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language (PR Newswire)
Sep-11-25 10:57PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
Sep-08-25 03:35PM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.

PresidentMr. Jeffrey N. Simmons

Executive VP & CFOMr. Robert M. VanHimbergen

Executive VP & President of Elanco InternationalDr. Ramiro Martin Cabral

Executive Vice President of ResearchDr. Ellen de Brabander Ph.D.

Executive Vice President of Center of Strategic GrowthMr. Timothy J. Bettington

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Neill Shiv	GC AND CORP SEC	Aug 18 '26	Buy	23.58	3,998	94,273	87,832	Aug 18 04:32 PM
Harrington Michael J	Director	Aug 12 '26	Buy	21.82	5,000	109,100	131,451	Aug 13 04:28 PM
VanHimbergen Robert M	EVP and CFO	Aug 07 '26	Buy	23.08	4,200	96,926	137,516	Aug 10 04:14 PM
Herendeen Paul	Director	Aug 07 '26	Buy	23.68	10,000	236,850	111,687	Aug 10 04:13 PM
Modi Rajeev A.	SEE REMARKS	May 15 '26	Buy	20.35	4,911	99,939	160,812	May 19 04:39 PM
Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR	May 15 '26	Buy	20.09	4,971	99,843	171,971	May 19 04:38 PM
Kurzius Lawrence Erik	Director	Dec 12 '25	Buy	21.30	10,000	213,000	131,773	Dec 16 04:42 PM
Modi Rajeev A.	SEE REMARKS	Dec 11 '25	Buy	21.33	4,500	95,985	123,082	Dec 15 04:43 PM
VanHimbergen Robert M	EVP and CFO	Dec 11 '25	Buy	21.64	6,950	150,426	124,233	Dec 15 04:42 PM
Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR	Dec 11 '25	Buy	21.75	22,000	478,496	167,000	Dec 15 04:41 PM

Peers: MPAA STRT SMP MNRO GT VC THRM BWA LEA GTX

| Held by: AVUV VTI IWM VXF IWN DFMC FSCC VTWO SCHA IWC

Index	RUT
Market Cap	204.80M
Enterprise Value	290.16M
Income	-109.66M
Sales	757.65M
Book/sh	5.23
Cash/sh	2.51
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4200
IPO	Oct 10, 1997

P/E	-
Forward P/E	-
PEG	-
P/S	0.27
P/B	1.37
P/C	2.86
P/FCF	-
EV/EBITDA	22.22
EV/Sales	0.38
Quick Ratio	1.27
Current Ratio	1.89
Debt/Eq	1.05
LT Debt/Eq	1.05
Option/Short	Yes / Yes

EPS (ttm)	-3.92
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-92.86% -65.92%
Sales past 3/5Y	-1.45% 5.85%
EPS Y/Y TTM	-264.88%
Sales Y/Y TTM	-13.70%
EPS Q/Q	44.54%
Sales Q/Q	-20.43%
Earnings	Aug 05 AMC
EPS/Sales Surpr.	- 12.07%

Insider Own	2.99%
Insider Trans	1.43%
Inst Own	80.85%
Inst Trans	4.57%
ROA	-18.56%
ROE	-51.92%
ROIC	-35.84%
Gross Margin	19.60%
Oper. Margin	-2.16%
Profit Margin	-14.47%
SMA20	-0.20%
SMA50	-0.48%
SMA200	6.94%
Trades

Shs Outstand	28.52M
Shs Float	27.67M
Short Float	3.62%
Short Ratio	4.42
Short Interest	1.00M
52W High	9.71 -26.06%
52W Low	4.60 56.09%
Volatility	3.81% 4.84%
ATR (14)	0.33
RSI (14)	50.24
Beta	1.89
Rel Volume	0.00
Avg Volume	226.60K
Volume	20

Perf Week	3.76%
Perf Month	-2.58%
Perf Quarter	7.00%
Perf Half Y	-18.59%
Perf YTD	24.01%
Perf Year	-9.57%
Perf 3Y	-66.16%
Perf 5Y	-69.74%
Perf 10Y	-57.57%
Recom	1.00
Target Price	16.00
Prev Close	7.01
Price	7.18
Change %	2.43%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-16-26	Downgrade	Barrington Research	Outperform → Mkt Perform
Aug-03-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-13-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-02-21	Upgrade	Barrington Research	Mkt Perform → Outperform	$45
Feb-26-21	Downgrade	CL King	Buy → Neutral
Feb-27-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-20-18	Initiated	Buckingham Research	Buy	$37
Apr-23-18	Initiated	CL King	Buy	$34
Apr-03-18	Initiated	Barrington Research	Outperform	$34
Mar-20-18	Upgrade	Stephens	Equal-Weight → Overweight
Mar-06-18	Reiterated	B. Riley FBR, Inc.	Neutral	$21 → $24
May-31-16	Downgrade	Sidoti	Buy → Neutral
Sep-28-15	Upgrade	BB&T Capital Mkts	Hold → Buy	$14
Jul-31-15	Upgrade	B. Riley & Co.	Neutral → Buy	$15.50
Nov-19-14	Initiated	FBR Capital	Mkt Perform	$13
Nov-07-14	Downgrade	BB&T Capital Mkts	Buy → Hold
Jul-15-13	Downgrade	B. Riley & Co.	Buy → Neutral	$12.50 → $13.50
May-10-13	Upgrade	BB&T Capital Mkts	Hold → Buy
Sep-24-12	Downgrade	BB&T Capital Mkts	Buy → Hold
Feb-14-12	Downgrade	KeyBanc Capital Mkts	Buy → Hold	$13

Show Previous Ratings

Aug-10-26 02:00PM	Stoneridge to Debut EVO ECU Platform Designed to Simplify the Future of Commercial Vehicles at IAA Transportation (PR Newswire)
Aug-06-26 03:05PM	Stoneridge Inc (SRI) (Q2 2026) Earnings Call Highlights: Record Mirror Eye Sales and Fastest ... (GuruFocus.com)
Aug-05-26 05:09PM	Stoneridge: Q2 Earnings Snapshot (Associated Press)
05:00PM	Stoneridge Reports Second Quarter 2026 Results (PR Newswire)
Jul-27-26 02:00PM	Stoneridge Announces Largest MirrorEye Camera Monitor System Bus and Coach Program to Date (PR Newswire)
05:00PM	Loading…
Jul-22-26 05:00PM	Stoneridge, Inc. Schedules Second Quarter 2026 Financial Results and Earnings Conference Call (PR Newswire)
Jun-30-26 03:55PM	Stoneridge Returns to Russell 2000 Index (PR Newswire)
Jun-25-26 08:00AM	Stoneridge to Showcase EVO ECU Platform and Next-Generation Vision Technology at IAA Transportation 2026 (PR Newswire)
Jun-03-26 05:00PM	Stoneridge Appoints Scott Humphrey as Chief Financial Officer (PR Newswire)
May-07-26 07:42AM	Stoneridge: Q1 Earnings Snapshot (Associated Press) +8.07%
07:30AM	Stoneridge Reports First Quarter 2026 Results (PR Newswire)
May-04-26 08:30AM	Stoneridge, Inc. to Broadcast its First Quarter 2026 Conference Call on the Web (PR Newswire)
Apr-28-26 04:40PM	Stoneridge's MirrorEye Camera Monitor System Continues Strong Momentum, Achieving Record Global Sales and Production Milestones (PR Newswire) -6.97%
Mar-12-26 08:30AM	Stoneridge, Inc. Q4 2025 Earnings Call Summary (Moby) -22.58%
Mar-11-26 08:51PM	Stoneridge: Q4 Earnings Snapshot (Associated Press Finance)
08:05PM	Loading…
08:05PM	Stoneridge Reports Fourth Quarter and Full-Year 2025 Results (PR Newswire)
Mar-02-26 05:00PM	Stoneridge, Inc. to Broadcast Its Fourth Quarter 2025 Conference Call on the Web (PR Newswire)
Feb-26-26 05:00PM	Stoneridge Announces Appointment of New Independent Director (PR Newswire)
Feb-23-26 04:30PM	Stoneridge Announces President and Chief Executive Officer Retirement and Leadership Succession Plan (PR Newswire) -5.79%
Feb-03-26 02:04AM	Stoneridge Sells Control Devices for $59M, Targets Debt Paydown and Sharper Tech Focus (MarketBeat)
Feb-02-26 05:20PM	Stoneridge Announces Chief Financial Officer Departure (PR Newswire) +15.35%
07:30AM	Stoneridge Completes Strategic Review with Sale of Control Devices Segment (PR Newswire)
Nov-05-25 05:16PM	Stoneridge: Q3 Earnings Snapshot (Associated Press Finance) -16.28%
05:00PM	Stoneridge Reports Third Quarter 2025 Results (PR Newswire)
Oct-23-25 05:00PM	Stoneridge, Inc. To Broadcast Its Third Quarter 2025 Conference Call On The Web (PR Newswire)
Aug-06-25 05:49PM	Stoneridge: Q2 Earnings Snapshot (Associated Press Finance) +9.31%
05:00PM	Stoneridge Reports Second Quarter 2025 Results (PR Newswire)
Jul-31-25 08:00AM	Stoneridge Launches Next-Generation MirrorEye® System for Buses and Rigid Vehicles in Europe (PR Newswire)
Jul-22-25 12:00PM	Stoneridge, Inc. To Broadcast Its Second Quarter 2025 Conference Call On The Web (PR Newswire) +8.12%
08:57AM	Ewing Morris Calls for Strategic Alternatives Review to Unlock Value at Stoneridge (PR Newswire)
08:50AM	Loading…
Jul-11-25 08:50AM	Stoneridge (SRI) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Jun-04-25 07:52AM	Stoneridge to Present at the Deutsche Bank Global Auto Industry Conference (PR Newswire)
May-30-25 07:30AM	Sparton Announces Closing of Sale of a 25 Per Cent Interest in Bruell Gold Project Claims, Quebec (GlobeNewswire)
May-07-25 08:00AM	Stoneridge Launches Next-Generation SE5000 Smart 2 Tachograph For European Commercial Vehicles (PR Newswire)
May-02-25 03:08AM	Stoneridge Inc (SRI) Q1 2025 Earnings Call Highlights: Strong Performance with Notable Margin ... (GuruFocus.com) +5.54%
May-01-25 11:21PM	Q1 2025 Stoneridge Inc Earnings Call (Thomson Reuters StreetEvents) +7.51%
09:38PM	Stoneridge, Inc. (SRI) Q1 2025 Earnings Call Transcript (Seeking Alpha)
Apr-30-25 05:40PM	Stoneridge: Q1 Earnings Snapshot (Associated Press Finance)
05:18PM	Stoneridge Reports First Quarter 2025 Results (PR Newswire)
Apr-17-25 05:00PM	Stoneridge, Inc. To Broadcast Its First Quarter 2025 Conference Call On The Web (PR Newswire)
Apr-01-25 09:48AM	Why Stoneridge Inc (SRI) is Plunging in 2025? (Insider Monkey)
Mar-18-25 04:37AM	Stoneridge (SRI): One of the Best Short-Term Stocks to Buy Right Now (Insider Monkey)
Mar-14-25 04:30PM	Stoneridge Announces Board of Director Changes (PR Newswire) +5.70%
Mar-11-25 09:17AM	Stoneridge (SRI) Fell Due to Weak Earnings (Insider Monkey)
Feb-28-25 02:17AM	Stoneridge Inc (SRI) Q4 2024 Earnings Call Highlights: Strong Cash Flow and Mirra Revenue ... (GuruFocus.com) +10.85%
Feb-27-25 01:00PM	Stoneridge to Source 100% Renewable Energy at Lexington Manufacturing Facility (PR Newswire) +20.71%
Feb-26-25 05:19PM	Stoneridge: Q4 Earnings Snapshot (Associated Press Finance)
04:54PM	Stoneridge Reports Fourth Quarter and Full-Year 2024 Results (PR Newswire)
08:16AM	Earnings To Watch: Stoneridge Inc (SRI) Reports Q4 2024 Result (GuruFocus.com)
Feb-13-25 05:00PM	Stoneridge, Inc. To Broadcast Its Fourth Quarter 2024 Conference Call On The Web (PR Newswire)
Nov-29-24 07:52AM	Heres Why Meridian Small Cap Growth Fund Maintained its Position in Stoneridge (SRI) (Insider Monkey)
Nov-12-24 05:00PM	Stoneridge to Present at the 2024 Stephens Annual Investment Conference (PR Newswire)
Nov-02-24 11:30AM	Stoneridge price target lowered to $16 from $25-$30 at Barrington (TipRanks)
Nov-01-24 05:00PM	Stoneridge Inc (SRI) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Oct-30-24 05:18PM	Stoneridge: Q3 Earnings Snapshot (Associated Press Finance) -24.68%
05:00PM	Stoneridge Reports Third Quarter 2024 Results (PR Newswire)
09:20AM	Stoneridge Inc (SRI) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-28-24 05:00PM	Stoneridge Announces Next MirrorEye Program on New Freightliner Fifth Generation Cascadia (PR Newswire) +5.37%
Oct-22-24 08:00AM	DB Schenker Pilots Stoneridge's MirrorEye Camera Monitor System on North American Fleet (PR Newswire)
Oct-17-24 05:00PM	Stoneridge, Inc. To Broadcast Its Third Quarter 2024 Conference Call On The Web (PR Newswire)
Oct-09-24 03:46PM	Stoneridge Inc (SRI) Q2 2024 Earnings Call Highlights: Margin Gains and Strategic Partnerships ... (GuruFocus.com)
Sep-04-24 05:00PM	Stoneridge to Present at CL King's 22nd Annual Best Ideas Conference (PR Newswire)
Jul-31-24 05:47PM	Stoneridge: Q2 Earnings Snapshot (Associated Press Finance) +6.19%
05:00PM	Stoneridge Reports Second Quarter 2024 Results (PR Newswire)
Jul-30-24 05:00PM	Stoneridge to Present at 2024 J.P. Morgan Auto Conference (PR Newswire)
Jul-18-24 05:00PM	Stoneridge, Inc. To Broadcast Its Second Quarter 2024 Conference Call On The Web (PR Newswire)
Jul-12-24 08:01AM	Methode Electronics, Inc. (NYSE:MEI) Q4 2024 Earnings Call Transcript (Insider Monkey)
Jun-05-24 05:00PM	Stoneridge to Present at the Deutsche Bank Global Auto Industry Conference (PR Newswire)
May-22-24 05:10PM	Stoneridge Appoints Natalia Noblet as President of Electronics Division (PR Newswire)
May-06-24 09:37AM	Stoneridge, Inc. (NYSE:SRI) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 03:25AM	Stoneridge Inc (SRI) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Margin Expansion (GuruFocus.com)
12:04AM	Q1 2024 Stoneridge Inc Earnings Call (Thomson Reuters StreetEvents)
May-01-24 06:13PM	Stoneridge Inc (SRI) Q1 2024 Earnings: Misses EPS Estimates Amidst Operational Challenges (GuruFocus.com)
05:12PM	Stoneridge: Q1 Earnings Snapshot (Associated Press Finance)
04:50PM	Stoneridge Reports First Quarter 2024 Results (PR Newswire)
Apr-18-24 05:00PM	Stoneridge, Inc. To Broadcast Its First-Quarter 2024 Conference Call On The Web (PR Newswire)
Apr-10-24 10:00AM	Stoneridge Releases Inaugural Sustainability Report (PR Newswire) -7.18%
Mar-22-24 11:00AM	Cargo Transporters, Inc. Adopts Stoneridge's MirrorEye Camera Monitor System (PR Newswire)
Mar-14-24 04:30PM	Stoneridge Appoints Troy Cooprider as Chief Technology Officer (PR Newswire)
Mar-08-24 01:29AM	Director Kim Korth Sells 7,745 Shares of Stoneridge Inc (SRI) (GuruFocus.com)
Mar-05-24 11:10AM	Grote, Stoneridge Showcase Smart Trailer Tech (Transport Topics)
Mar-01-24 08:59AM	Stoneridge, Inc. (NYSE:SRI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 11:11PM	Q4 2023 Stoneridge Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 06:10PM	Stoneridge: Q4 Earnings Snapshot (Associated Press Finance)
05:52PM	Stoneridge Inc (SRI) Reports Q4 2023 Results and Provides 2024 Outlook (GuruFocus.com)
05:10PM	Stoneridge Reports Fourth Quarter 2023 Results (PR Newswire)
Feb-27-24 05:00PM	Stoneridge Launching MirrorEye Camera Monitor System with Volvo Trucks on Global Heavy-Duty Truck Platforms (PR Newswire)
Feb-15-24 05:00PM	Stoneridge, Inc. To Broadcast Its Fourth-Quarter 2023 Conference Call On The Web (PR Newswire)
Feb-02-24 05:00PM	Stoneridge's MirrorEye Camera Monitor System Receives FMCSA Exemption Renewal (PR Newswire)
Jan-31-24 05:00PM	Stoneridge Publishes Inaugural Task Force for Climate-Related Financial Disclosures (TCFD) Report (PR Newswire)
Jan-18-24 09:40AM	Are Investors Undervaluing Stoneridge (SRI) Right Now? (Zacks)
Dec-29-23 09:40AM	Is Stoneridge (SRI) Stock Undervalued Right Now? (Zacks)
Dec-26-23 08:50AM	Fast-paced Momentum Stock Stoneridge (SRI) Is Still Trading at a Bargain (Zacks)
Dec-19-23 06:34AM	Here's Why ClearBridge Small Cap Growth Strategy Sold Stoneridge (SRI) (Insider Monkey)
Dec-12-23 09:40AM	Should Value Investors Buy Stoneridge (SRI) Stock? (Zacks)
Nov-07-23 05:00PM	Stoneridge to Present at the Stephens Annual Investment Conference (PR Newswire)
Nov-04-23 10:52AM	Stoneridge, Inc. (NYSE:SRI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 08:25AM	STONERIDGE, INC. ANNOUNCES REFINANCING OF ITS EXISTING CREDIT FACILITY WITH NEW $275 MILLION SENIOR SECURED REVOLVING CREDIT FACILITY (PR Newswire)
Nov-01-23 07:17PM	Stoneridge Inc (SRI) Reports Q3 2023 Earnings with Sales of $238.2 Million (GuruFocus.com)
06:30PM	Stoneridge: Q3 Earnings Snapshot (Associated Press Finance)

Stoneridge, Inc. engages in the production of engineered electrical and electronic components, modules, and systems for the automotive, commercial, off-highway, motorcycle, and agricultural vehicle markets. It operates through the following segments: Control Devices, Electronics, and Stoneridge Brazil. The Control Devices segment designs and manufactures products that monitor, measure, and activate specific functions within a vehicle such as sensors, switches, valves, and actuators. The Electronics segment offers driver information systems, camera-based vision systems, connectivity and compliance products, and electronic control units. The Stoneridge Brazil segment sells vehicle tracking devices and monitoring services, vehicle security alarms and convenience accessories, in-vehicle audio and infotainment devices, and telematics solutions. The company was founded by D. M. Draime in 1965 and is headquartered in Novi, MI.

PresidentMs. Natalia Noblet

Chief Human Resources Officer & Assistant General CounselMs. Susan C. Benedict

Strategic AdvisorMr. James Zizelman

CFO & TreasurerMr. Scott Randall Humphrey

Global Vice President of OperationsMs. Amy Meyer

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Humphrey Scott Randall	CFO and Treasurer	Aug 18 '26	Buy	7.01	6,000	42,060	6,000	Aug 18 12:34 PM
Noblet Natalia	President and CEO	Aug 10 '26	Buy	7.31	5,000	36,550	5,000	Aug 11 04:16 PM
Ferraiolo Caetano Roberto	President Stoneridge Brazil	Jun 15 '26	Sale	7.55	9,000	67,950	3,996	Jun 18 03:14 PM
Ferraiolo Caetano Roberto	Officer	Jun 15 '26	Proposed Sale	7.60	9,000	68,400		Jun 15 03:46 PM
LASKY WILLIAM M	Director	Jun 12 '26	Buy	7.46	5,000	37,300	192,666	Jun 12 10:30 AM
Kaplan Ira C.	Director	Jun 03 '26	Buy	7.54	5,000	37,700	100,046	Jun 04 04:29 PM
Zizelman James	President and CEO	May 20 '26	Option Exercise	0.00	430,663	0	462,102	May 22 09:47 AM
Ferraiolo Caetano Roberto	President Stoneridge Brazil	Mar 02 '26	Option Exercise	0.00	4,961	0	14,333	Mar 04 02:39 PM
Hartman Robert J. Jr.	Chief Accounting Officer	Mar 02 '26	Option Exercise	0.00	3,148	0	39,265	Mar 04 02:33 PM
Horvath Matthew R.	Chief Financial Officer	Mar 02 '26	Option Exercise	0.00	9,052	0	22,940	Mar 04 02:27 PM
Benedict Susan C.	CHRO and Assistant GC	Mar 02 '26	Option Exercise	0.00	7,396	0	20,468	Mar 04 02:16 PM
Zizelman James	President and CEO	Mar 02 '26	Option Exercise	0.00	19,363	0	39,058	Mar 04 02:08 PM

Peers: BFRG MGRX VSEE HCTI MNDR ZCMD BEAT ONMD DRIO DH

| Held by: VXF

Index	-
Market Cap	7.49M
Enterprise Value	-8.82M
Income	-9.20M
Sales	0.08M
Book/sh	6.91
Cash/sh	5.66
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	11
IPO	Apr 22, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	93.62
P/B	0.38
P/C	0.46
P/FCF	-
EV/EBITDA	-
EV/Sales	-110.25
Quick Ratio	16.20
Current Ratio	16.20
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-7.60
EPS next Y	-5.37
EPS next Q	-1.05
EPS this Y	66.96%
EPS next Y	-19.07%
EPS next 5Y	-
EPS past 3/5Y	95.75% 83.48%
Sales past 3/5Y	7.80% 9.25%
EPS Y/Y TTM	99.74%
Sales Y/Y TTM	33.07%
EPS Q/Q	59.40%
Sales Q/Q	30.48%
Earnings	Jun 03
EPS/Sales Surpr.	0.00% 0.00%

Insider Own	27.01%
Insider Trans	8.66%
Inst Own	4.00%
Inst Trans	3.83%
ROA	-56.09%
ROE	-58.97%
ROIC	-54.09%
Gross Margin	-267.68%
Oper. Margin	-11592.14%
Profit Margin	-10978.48%
SMA20	10.67%
SMA50	-3.41%
SMA200	-32.51%
Trades

Shs Outstand	2.46M
Shs Float	2.10M
Short Float	1.54%
Short Ratio	0.46
Short Interest	0.03M
52W High	12.03 -78.39%
52W Low	1.95 33.33%
Volatility	8.48% 8.10%
ATR (14)	0.18
RSI (14)	54.34
Beta	1.25
Rel Volume	0.00
Avg Volume	70.54K
Volume	0

Perf Week	14.04%
Perf Month	-1.14%
Perf Quarter	-18.75%
Perf Half Y	0.39%
Perf YTD	-43.48%
Perf Year	-64.27%
Perf 3Y	-100.00%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	7.50
Prev Close	2.60
Price	2.60
Change %	0.00%

Aug-12-26 07:00AM	Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process (GlobeNewswire)
Aug-04-26 07:00AM	Aclarion Announces Nociscan Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology (GlobeNewswire)
Jul-29-26 07:00AM	Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026 (GlobeNewswire) -5.40%
Jul-21-26 07:00AM	Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan's Growing Role in Real-World Clinical Practice (GlobeNewswire)
Jul-07-26 07:00AM	Aclarion Announces Texas Spine Care Center as New CLARITY Site (GlobeNewswire)
07:00AM	Loading…
Jun-10-26 07:00AM	Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub (GlobeNewswire)
Jun-09-26 07:00AM	Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform (GlobeNewswire)
Jun-08-26 07:05AM	Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal (GlobeNewswire) -5.88%
07:00AM	Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting (GlobeNewswire)
Jun-03-26 06:00AM	Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation (GlobeNewswire)
Jun-01-26 06:00AM	Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study (GlobeNewswire)
May-28-26 02:49PM	Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal (GlobeNewswire)
08:00AM	Echo Lake Capital Offers To Acquire Aclarion Inc. (ACCESSWIRE)
May-07-26 06:00AM	Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment (GlobeNewswire)
May-06-26 06:00AM	Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. (GlobeNewswire)
06:00AM	Loading…
May-05-26 06:00AM	Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine (GlobeNewswire)
Apr-30-26 06:00AM	Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption (GlobeNewswire)
Apr-28-26 06:00AM	Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan (GlobeNewswire)
Apr-22-26 08:30AM	Aclarion Announces $2.5 Million Stock Repurchase Plan (GlobeNewswire) +5.67%
Apr-16-26 06:47AM	Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain (GlobeNewswire)
Apr-14-26 08:00AM	Aclarion Receives Pinnacle Award for AI Innovation (GlobeNewswire)
Apr-08-26 08:00AM	Aclarion Announces Agreement with Weill Cornell Medicine (GlobeNewswire)
Apr-07-26 08:00AM	Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video (GlobeNewswire)
Mar-24-26 08:00AM	Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. (ACCESSWIRE) +10.58%
Mar-19-26 09:25AM	Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan (GlobeNewswire)
06:00AM	Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts (GlobeNewswire)
Mar-17-26 06:00AM	Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet (GlobeNewswire)
Mar-12-26 06:00AM	Aclarion CEO Brent Ness to Attend LSI USA 2026 (GlobeNewswire)
Feb-05-26 06:00AM	Aclarion Publishes 2026 Shareholder Letter from the Chairman (GlobeNewswire) -12.59%
Feb-03-26 06:00AM	Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation (GlobeNewswire)
10:51AM	Loading…
Jan-13-26 10:51AM	Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout (Benzinga) -6.87%
06:00AM	Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 (GlobeNewswire)
Jan-08-26 08:29AM	Aclarion's AI Back Pain Tech Sees 114% Surge In Demand, Stock Soars (Benzinga) +42.09%
06:00AM	Aclarion Provides 2025 Update and 2026 Corporate Outlook (GlobeNewswire)
Jan-06-26 06:00AM	Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data (GlobeNewswire)
Dec-04-25 08:00AM	Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) (GlobeNewswire) +5.55%
Dec-02-25 08:00AM	Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. (GlobeNewswire) +10.31%
Nov-05-25 06:00AM	Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion (GlobeNewswire)
Oct-22-25 06:00AM	Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH (GlobeNewswire)
Oct-14-25 06:09AM	Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst (GlobeNewswire) -7.64%
Oct-13-25 06:00AM	Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference (GlobeNewswire) +12.71%
Oct-09-25 06:00AM	Aclarion to Present at the LD Micro Main Event XIX (Newsfile) -5.39%
Oct-07-25 06:00AM	Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH (GlobeNewswire)
Oct-01-25 07:17AM	Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers (GlobeNewswire)
Sep-25-25 06:00AM	First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial (GlobeNewswire)
Sep-03-25 06:00AM	Aclarion Appoints Greg Gould as Chief Financial Officer (GlobeNewswire)
Aug-07-25 06:05PM	AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates (Zacks)
Aug-05-25 06:00AM	Auddia Announces Non-binding Letter of Intent for Business Combination and Restructuring (GlobeNewswire) +5.71%
06:00AM	Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts (GlobeNewswire)
Jul-07-25 04:01PM	Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
Jun-25-25 06:00AM	First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial (GlobeNewswire)
Jun-24-25 07:00AM	Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum (GlobeNewswire)
Jun-10-25 06:00AM	Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site (GlobeNewswire)
May-20-25 06:00AM	Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site (GlobeNewswire)
May-12-25 07:34AM	Aclarion Announces Texas Back Institute as New CLARITY Trial Site (GlobeNewswire) +7.04%
May-05-25 06:00AM	Aclarion Welcomes Advocate Health as CLARITY Trial Site (GlobeNewswire)
Apr-29-25 06:00AM	Aclarion Announces Commercial Agreement with Spine Institute of Louisiana (GlobeNewswire)
Apr-23-25 06:00AM	Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 (GlobeNewswire)
Apr-21-25 06:00AM	Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis (GlobeNewswire) -11.69%
Apr-09-25 07:00AM	Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub (GlobeNewswire) +9.85%
Apr-02-25 06:00AM	Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California (GlobeNewswire) +11.49%
Mar-31-25 07:00AM	Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives (GlobeNewswire) -10.89%
Mar-26-25 07:00AM	Aclarion Announces Reverse Stock Split (GlobeNewswire) -23.03%
Mar-13-25 09:25AM	Aclarion Provides Shareholder Update (GlobeNewswire) -15.94%
Mar-07-25 09:45AM	Aclarion announces expansion plans with RadNet affiliates in NY, NJ (TipRanks) -13.75%
Mar-06-25 09:35AM	Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey (GlobeNewswire) -77.14%
Mar-03-25 06:00AM	Aclarion Announces First Commercial Agreement with Scripps Health (GlobeNewswire) +126.87%
Feb-28-25 04:01PM	Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders (GlobeNewswire) +27.38%
Feb-20-25 12:31PM	Aclarion, Inc. (ACON) to Showcase NOCISCAN's Impact on Spine Surgery at 2025 Spine Summit (Insider Monkey) +16.85%
06:00AM	Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit (GlobeNewswire)
Feb-11-25 07:58AM	Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body (GlobeNewswire) -10.28%
Feb-06-25 07:23AM	Aclarion Announces Northwestern Medicine as First CLARITY Trial Site (GlobeNewswire)
Feb-04-25 07:23AM	Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded (GlobeNewswire)
Jan-31-25 11:59AM	Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference (GlobeNewswire) -15.48%
Jan-30-25 03:13PM	Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market (NewMediaWire) -8.82%
Jan-28-25 10:51AM	Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split (NewMediaWire) -17.02%
Jan-24-25 05:30PM	Aclarion Announces Reverse Stock Split (NewMediaWire) +27.08% -30.42%
Jan-17-25 04:43PM	Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants (NewMediaWire) -6.00%
Jan-15-25 09:15AM	Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants (NewMediaWire) -55.64%
Jan-07-25 07:28AM	Aclarion, Inc. Raises Funds Through Stock Offering (TipRanks) -6.70%
Jan-03-25 04:11PM	Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market (NewMediaWire) +110.14% -42.96%
Dec-03-24 03:45PM	Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing (ACCESS Newswire)
Nov-21-24 08:00AM	Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash (GlobeNewswire)
Nov-14-24 05:00PM	Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st (ACCESSWIRE)
Oct-10-24 07:00AM	Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire)
Sep-27-24 06:57AM	Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes (GlobeNewswire)
Sep-13-24 08:30AM	PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology (GlobeNewswire)
Sep-12-24 06:57AM	Aclarion Provides Corporate Update on Nociscan AI Technology Milestones (GlobeNewswire) +15.38%
06:00AM	Transforming Oncology: Stocks to Watch in the Oncology Sector (News Direct)
Sep-11-24 01:00PM	Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing (ACCESSWIRE)
06:00AM	Aclarion, Inc.'s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector (News Direct)
Sep-10-24 06:57AM	Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial (GlobeNewswire)
Sep-06-24 11:27AM	Aclarion Added to PRISM Emerging Medical Devices Index (GlobeNewswire)
Sep-05-24 06:57AM	Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market (GlobeNewswire) -6.49%
Aug-29-24 06:57AM	Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey (GlobeNewswire) -5.20%
Aug-21-24 07:57AM	Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans (GlobeNewswire)
Aug-15-24 09:48AM	Aclarion to Present at August 20th Virtual Investor Summit Microcap Event (GlobeNewswire) +10.48%
Aug-14-24 08:08AM	Aclarion Announces First Commercial Agreement in Michigan (GlobeNewswire) -10.27%
Aug-13-24 09:07AM	Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK (GlobeNewswire) -16.98%
Jul-09-24 07:00AM	Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK (GlobeNewswire)

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Executive ChairmanDr. Jeffrey John Thramann M.D.

CEOMr. Brent Ness

Chief Financial OfficerMr. Gregory A. Gould CPA

Chief Strategy OfficerMr. Ryan Bond

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gould Gregory A	CFO	Aug 14 '26	Buy	2.45	10,000	24,500	60,000	Aug 18 08:30 AM
Bond Ryan	Director	Aug 13 '26	Buy	2.37	21,122	50,059	76,122	Aug 17 08:30 AM
Wesemann William	Director	Aug 13 '26	Buy	2.34	2,150	5,031	23,713	Aug 17 08:30 AM
Neal David K	Director	Aug 13 '26	Buy	2.40	7,500	18,000	30,002	Aug 17 08:30 AM
Ness Brent	Chief Executive Officer	Aug 13 '26	Buy	2.31	5,234	12,091	111,534	Aug 17 08:30 AM
Breidbart Scott	Director	May 12 '26	Buy	3.18	5,664	18,012	5,664	May 12 06:53 PM
Neal David K	Director	May 11 '26	Buy	3.10	2,500	7,750	2,502	May 12 08:30 AM
Ness Brent	Chief Executive Officer	May 11 '26	Buy	3.18	6,289	19,999	6,300	May 11 04:30 PM
Wesemann William	Director	May 06 '26	Buy	3.30	1,562	5,155	1,563	May 08 05:00 PM
Ness Brent	Chief Executive Officer	Nov 26 '25	Buy	6.20	10	62	11	Dec 01 05:00 PM

Peers: IIIN MEC ESAB WOR LECO KMT TKR WS NUE STLD

| Held by: VTI IWM AVUV VXF IWN FNDA DFAT VTWO IWC DFMC

Index	RUT
Market Cap	279.55M
Enterprise Value	323.06M
Income	32.76M
Sales	781.74M
Book/sh	6.57
Cash/sh	0.49
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Jun 15, 2023
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	1700
IPO	Jul 05, 1989

P/E	8.49
Forward P/E	-
PEG	-
P/S	0.36
P/B	1.22
P/C	16.27
P/FCF	12.35
EV/EBITDA	5.73
EV/Sales	0.41
Quick Ratio	1.01
Current Ratio	1.73
Debt/Eq	0.27
LT Debt/Eq	0.25
Option/Short	Yes / Yes

EPS (ttm)	0.94
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-6.59% -
Sales past 3/5Y	-8.34% -0.87%
EPS Y/Y TTM	8162.28%
Sales Y/Y TTM	14.97%
EPS Q/Q	246.79%
Sales Q/Q	20.72%
Earnings	Aug 07 BMO
EPS/Sales Surpr.	- -

Insider Own	7.87%
Insider Trans	-18.67%
Inst Own	67.06%
Inst Trans	5.57%
ROA	8.34%
ROE	15.47%
ROIC	11.43%
Gross Margin	13.72%
Oper. Margin	4.18%
Profit Margin	4.19%
SMA20	2.11%
SMA50	2.61%
SMA200	-1.52%
Trades

Shs Outstand	34.81M
Shs Float	32.19M
Short Float	1.68%
Short Ratio	3.16
Short Interest	0.54M
52W High	10.53 -24.03%
52W Low	6.25 28.00%
Volatility	2.84% 4.33%
ATR (14)	0.33
RSI (14)	53.00
Beta	0.78
Rel Volume	0.00
Avg Volume	170.78K
Volume	0

Perf Week	1.27%
Perf Month	5.96%
Perf Quarter	7.38%
Perf Half Y	-8.47%
Perf YTD	11.42%
Perf Year	8.99%
Perf 3Y	60.32%
Perf 5Y	-36.36%
Perf 10Y	-37.30%
Recom	3.00
Target Price	17.00
Prev Close	8.00
Price	8.00
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-04-15	Initiated	Macquarie	Neutral	$23
Apr-16-08	Downgrade	Davenport	Buy → Neutral	$19
Jan-09-08	Upgrade	Davenport	Neutral → Buy	$19
Aug-08-07	Upgrade	Davenport	Reduce/Sell → Neutral	$19
May-04-07	Initiated	Davenport	Reduce/Sell	$21

Aug-07-26 08:22AM	Tredegar: Q2 Earnings Snapshot (Associated Press) +14.71%
08:15AM	Tredegar Reports Second Quarter 2026 Results (Business Wire)
Aug-03-26 08:55AM	Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026 (Business Wire)
Jul-30-26 05:58PM	Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026 (Business Wire)
May-27-26 04:15PM	Tredegar Announces Director Transitions (Business Wire)
08:14AM	Loading…
May-08-26 08:14AM	Tredegar: Q1 Earnings Snapshot (Associated Press)
08:05AM	Tredegar Reports First Quarter 2026 Results (Business Wire)
Apr-08-26 11:00AM	Video - CEO Clips: Trifecta Gold Targets New Discoveries in Yukon's Tombstone Gold Belt (TMX Newsfile)
Mar-11-26 09:13AM	Tredegar: Q4 Earnings Snapshot (Associated Press Finance) -7.97%
08:15AM	Tredegar Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Mar-06-26 08:30AM	Tredegar Plans to Release Fourth Quarter 2025 Financial Results on March 11, 2026 (Business Wire)
Feb-25-26 08:30AM	Bonnell Aluminum Announces New Vice President of Sales and Marketing (Business Wire)
Feb-09-26 04:05PM	Tredegar Appoints David Parks to Board of Directors (Business Wire)
Dec-18-25 04:23AM	The Zacks Analyst Blog Alphabet, Tesla, Sony, Tredegar and CVD Equipment (Zacks)
Dec-17-25 04:21PM	Top Analyst Reports for Alphabet, Tesla & Sony (Zacks)
04:47PM	Loading…
Nov-20-25 04:47PM	Tredegar Announces Retirement of John M. Steitz (Business Wire)
Nov-13-25 08:44AM	TG's Q3 Earnings Surge Y/Y on Strong Aluminum Demand, Stock Up 33% (Zacks)
Nov-07-25 08:13AM	Tredegar: Q3 Earnings Snapshot (Associated Press Finance) +9.22%
08:05AM	Tredegar Reports Third Quarter 2025 Results (Business Wire)
Oct-17-25 06:29AM	The Zacks Analyst Blog Highlights NVIDIA, Roche, Lam Research, Tredegar and Kewaunee Scientific (Zacks)
Oct-16-25 05:04PM	Top Stock Reports for NVIDIA, Roche & Lam Research (Zacks)
Oct-06-25 04:05PM	Tredegar Announces the Retirement of D. Andrew Edwards, Chief Financial Officer and Executive Vice President, Effective December 31, 2025 (Business Wire)
Aug-14-25 01:45PM	Tredegar's Q2 Earnings Slide Y/Y on Cost, Volume Pressures (Zacks)
Aug-08-25 04:12PM	Tredegar: Q2 Earnings Snapshot (Associated Press Finance) -11.56%
04:05PM	Tredegar Reports Second Quarter 2025 Results (Business Wire)
Aug-04-25 04:15PM	Tredegar Plans to Release Second Quarter 2025 Financial Results on August 8, 2025 (Business Wire)
May-14-25 01:41PM	Tredegar Q1 Earnings Down Y/Y as Aluminum Costs Weigh on Margins (Zacks)
May-09-25 10:01AM	The Zacks Analyst Blog Highlights NVIDIA, Abbott Laboratories, Linde and Tredegar (Zacks)
May-08-25 04:17PM	Top Stock Reports for NVIDIA, Abbott Laboratories & Linde (Zacks)
08:21AM	Tredegar: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Loading…
08:00AM	Tredegar Reports First Quarter 2025 Results (Business Wire)
May-07-25 01:41PM	Tredegar Corporation (TG): A Bull Case Theory (Insider Monkey)
Apr-23-25 01:50AM	Tredegar: A Strong Balance Sheet Helps Navigate Uncertainty (Seeking Alpha)
Mar-12-25 08:43AM	Tredegar: Q4 Earnings Snapshot (Associated Press Finance) +12.24%
08:15AM	Tredegar Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Jan-15-25 08:30AM	Tredegar Appoints Chris Vlahcevic to Board of Directors (Business Wire)
Nov-08-24 04:24PM	Tredegar: Q3 Earnings Snapshot (Associated Press Finance) -20.27%
04:15PM	Tredegar Reports Third Quarter 2024 Results (Business Wire)
Nov-01-24 10:50AM	Tredegar Completes Sale of Terphane to Oben Group (Business Wire) +5.16%
Oct-31-24 08:30AM	Tredegar Surface Protection Launches New Packaging Film Optennia (Business Wire)
Oct-18-24 11:45AM	Tredegar Corporation (TG): A Bull Case Theory (Insider Monkey)
Oct-16-24 10:45AM	Competition Authority in Brazil Approves the Sale of Tredegars Terphane Business Unit to Oben Group; Transaction Expected to Close on November 1 (Business Wire) +10.97%
Oct-10-24 04:01PM	Tredegar Surface Protection Launches Innovative Obsidian Automotive Protective Films (Business Wire)
Oct-08-24 04:41PM	Bonnell Aluminum Sponsors AEC Apprenticeship Program (Business Wire)
Sep-30-24 05:11PM	Bonnell Aluminum Commenting on Final Determinations in Trade Cases on Aluminum Extrusions from 14 Countries (Business Wire)
Aug-08-24 12:33PM	Tredegar (TG) Q2 Earnings Rise Y/Y on Strength of PE Films Unit (Zacks)
Aug-07-24 08:12AM	Tredegar: Q2 Earnings Snapshot (Associated Press Finance) +7.37%
08:05AM	Tredegar Reports Second Quarter 2024 Results (Business Wire)
Aug-01-24 04:15PM	Tredegar Plans to Release Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire) -5.41%
Jul-17-24 06:25PM	Tredegar Corporation (TG): Is It the Best Small-Cap Stock to Buy Now? (Insider Monkey)
Jul-11-24 04:15PM	Bonnell Aluminum Commenting on Proclamation to Strengthen the Rules to Qualify for Trade Benefits Between the U.S. and Mexico (Business Wire) +5.81%
May-16-24 08:18AM	Spruce Power Holding Corporation (NYSE:SPRU) Q1 2024 Earnings Call Transcript (Insider Monkey) -6.46%
08:15AM	Update on the Brazilian Merger Review Process for the Sale of Terphane to Oben Group (Business Wire)
May-10-24 03:41PM	Tredegar Corp (TG) Reports Improved First Quarter 2024 Results Amidst Industry Challenges (GuruFocus.com)
May-09-24 08:14AM	Tredegar: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Tredegar Reports First Quarter 2024 Results (Business Wire)
May-02-24 06:00PM	Bonnell Aluminum Commenting on Preliminary Dumping Determinations (Business Wire)
May-01-24 08:30AM	Tredegar Will Host Virtual Annual Meeting of Shareholders; Announces Schedule for First-Quarter Earnings (Business Wire)
Mar-15-24 01:49PM	Spruce Power Holding Corporation (NYSE:SPRU) Q4 2023 Earnings Call Transcript (Insider Monkey) +26.43%
12:52PM	TG Stock Earnings: Tredegar Reported Results for Q4 2023 (InvestorPlace)
09:51AM	Tredegar Corp (TG) Faces Significant Net Loss in 2023 Amid Strategic Shifts and Market Challenges (GuruFocus.com)
08:43AM	Tredegar: Q4 Earnings Snapshot (Associated Press Finance)
08:39AM	Tredegar Q4 Net Loss Sharply Widens (RTT News)
08:15AM	Tredegar Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Mar-07-24 04:15PM	Tredegar Plans to Release Fourth Quarter 2023 Financial Results on March 15, 2024 (Business Wire) +5.98%
Mar-06-24 08:30AM	Bonnell Aluminum Commenting on Preliminary Countervailing Duty Ruling (Business Wire)
Feb-02-24 01:59PM	11 Best Aluminum and Aluminum Mining Stocks To Buy (Insider Monkey)
Dec-20-23 08:30AM	Terphane is Awarded GREAT PLACE TO WORK Best Place to Work - Industry in Brazil For Fourth Consecutive Year (Business Wire)
Dec-11-23 05:00AM	3 Underperforming Aluminum Stocks You Better Not Be Buying (InvestorPlace)
Nov-20-23 08:45AM	Bonnell Aluminum Commenting on Initial Determination by ITC (Business Wire)
Nov-09-23 05:50PM	Tredegar: Q3 Earnings Snapshot (Associated Press Finance)
04:57PM	Tredegar Reports Third Quarter 2023 Results (Business Wire)
Oct-05-23 09:15AM	Bonnell Aluminum Commenting on Recent Trade Filing from Aluminum Extruders Coalition and United Steelworkers Union (Business Wire)
Sep-21-23 01:24PM	10 Best Aluminum and Aluminum Mining Stocks To Buy (Insider Monkey)
Sep-01-23 04:33PM	Tredegar Agrees to Sell Terphane to Oben Group (Business Wire) +11.92%
Aug-09-23 08:23AM	Tredegar: Q2 Earnings Snapshot (Associated Press Finance) -20.25%
08:15AM	Tredegar Reports Second Quarter 2023 Results (Business Wire)
Aug-06-23 09:18AM	Are Tredegar Corporation's (NYSE:TG) Mixed Financials Driving The Negative Sentiment? (Simply Wall St.)
Aug-04-23 05:35PM	West Sacramento's Origin Materials signs supply agreement with plastics manufacturer Tredegar (American City Business Journals)
Aug-03-23 07:30AM	Origin Materials and Terphane Form Strategic Partnership to Produce Sustainable, High-Performance Packaging (Business Wire)
Aug-01-23 09:45PM	Tredegar Plans to Release Second Quarter 2023 Financial Results on August 9, 2023 (Business Wire)
Jul-14-23 07:54AM	With 58% institutional ownership, Tredegar Corporation (NYSE:TG) is a favorite amongst the big guns (Simply Wall St.)
Jun-27-23 08:07AM	Tredegar's (NYSE:TG) earnings trajectory could turn positive as the stock rallies 11% this past week (Simply Wall St.)
Jun-02-23 06:46PM	Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +5.51% -8.49%
May-31-23 07:06AM	Calculating The Intrinsic Value Of Tredegar Corporation (NYSE:TG) (Simply Wall St.)
May-08-23 08:21AM	Tredegar: Q1 Earnings Snapshot (AP Finance) -15.18%
08:15AM	Tredegar Reports First Quarter 2023 Results (Business Wire)
May-05-23 04:26PM	Tredegar Board Declares Quarterly Dividend (Business Wire)
Apr-26-23 08:00PM	TG: What does Argus have to say about TG? (Argus Research)
08:45AM	Tredegar Will Host Virtual Annual Meeting of Shareholders; Announces Schedule for First-Quarter Earnings (Business Wire)
Apr-04-23 08:45AM	TSLOTS Aluminum Framing System to Expand Operations into Southeastern U.S. (Business Wire)
Mar-16-23 08:31AM	Tredegar: Q4 Earnings Snapshot (AP Finance) -5.19%
08:15AM	Tredegar Reports Fourth Quarter and Full Year 2022 Results (Business Wire)
Mar-09-23 04:05PM	Tredegar Board Declares Quarterly Dividend (Business Wire)
11:05AM	Tredegar Plans to Release Fourth Quarter 2022 Financial Results on March 16, 2023 (Business Wire)
Feb-27-23 05:11AM	Tredegar Corporation's (NYSE:TG) Stock Is Going Strong: Have Financials A Role To Play? (Simply Wall St.)
Jan-18-23 05:53AM	Tredegar (NYSE:TG) shareholders have endured a 14% loss from investing in the stock three years ago (Simply Wall St.)
Jan-09-23 04:15PM	Tredegar Announces Retirement of John D. Gottwald (Business Wire)
Dec-22-22 05:14AM	A Look At The Fair Value Of Tredegar Corporation (NYSE:TG) (Simply Wall St.)
Nov-15-22 04:05PM	Tredegar Board Declares Quarterly Dividend (Business Wire)

Tredegar Corp. engages in the manufacture of polyethylene (PE) plastic films, polyester films, and aluminum extrusions. It operates through the following segments: PE Films, Flexible Packaging Films and Aluminum Extrusions. The PE Films segment manufactures plastic films, elastics, and laminate materials utilized in personal care materials, surface protection films and specialty and optical lighting applications. The Flexible Packaging Films segment produces polyester-based films for use in packaging applications. The Aluminum Extrusions segment provides soft-alloy and medium-strength aluminum extrusions for building and construction, automotive, consumer durables, machinery and equipment, electrical and distribution markets. The company was founded in 1988 and is headquartered in Richmond, VA.

Executive VPMr. Kevin Cyril Donnelly J.D.

CEODr. Arijit DasGupta

CFOMr. Frasier W. Brickhouse II

Controller & Principal Accounting OfficerMr. Paul Goldschmiedt

Director of Investor RelationsMs. Neill Bellamy

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DasGupta Arijit	See Remarks	Aug 18 '26	Buy	7.87	2,093	16,472	140,097	Aug 18 05:13 PM
DasGupta Arijit	See Remarks	Aug 14 '26	Buy	7.87	907	7,138	138,004	Aug 18 08:54 AM
GOTTWALD JOHN D	10% Owner	Aug 13 '26	Sale	8.00	1,020	8,163	377,429	Aug 17 02:44 PM
Gottwald James T.	10% Owner	Aug 13 '26	Sale	8.00	1,020	8,163	377,429	Aug 17 02:36 PM
GOTTWALD WILLIAM M	10% Owner	Aug 13 '26	Sale	8.00	1,021	8,171	377,428	Aug 17 02:31 PM
GOTTWALD JOHN D	10% Owner	Aug 11 '26	Sale	8.19	17,148	140,494	391,619	Aug 13 11:32 AM
GOTTWALD JOHN D	10% Owner	Aug 12 '26	Sale	8.07	13,170	106,321	378,449	Aug 13 11:32 AM
GOTTWALD WILLIAM M	10% Owner	Aug 11 '26	Sale	8.19	17,148	140,494	391,619	Aug 13 11:23 AM
GOTTWALD WILLIAM M	10% Owner	Aug 12 '26	Sale	8.07	13,170	106,321	378,449	Aug 13 11:23 AM
Gottwald James T.	10% Owner	Aug 11 '26	Sale	8.19	17,148	140,494	391,619	Aug 13 11:15 AM
Gottwald James T.	10% Owner	Aug 12 '26	Sale	8.07	13,170	106,321	378,449	Aug 13 11:15 AM
Residual 10-Year CLAT UA FDGJR	10% Owner	Aug 10 '26	Proposed Sale	8.47	349,441	2,959,765		Aug 10 04:42 PM
Tack Carl E. III	Former Director	Aug 05 '26	Proposed Sale	7.71	3,899	30,077		Aug 05 04:32 PM
Tack Carl E. III	Former Director	Jul 24 '26	Proposed Sale	7.75	8,283	64,193		Jul 24 04:09 PM
Tack Carl E. III	Former Director	Jul 23 '26	Proposed Sale	7.75	9,194	71,254		Jul 23 04:09 PM
Tack Carl E. III	Former Director	Jul 22 '26	Proposed Sale	7.75	282	2,186		Jul 22 04:22 PM
Tack Carl E. III	Former Director	Jun 26 '26	Proposed Sale	8.25	20,000	165,000		Jun 26 11:58 AM
GOTTWALD WILLIAM M	10% Owner	Jun 12 '26	Sale	8.16	20,145	164,444	408,767	Jun 15 02:26 PM
GOTTWALD WILLIAM M	10% Owner	Jun 11 '26	Sale	8.00	6,152	49,241	428,912	Jun 15 02:26 PM
GOTTWALD JOHN D	10% Owner	Jun 12 '26	Sale	8.16	20,146	164,452	408,767	Jun 15 02:23 PM
GOTTWALD JOHN D	10% Owner	Jun 11 '26	Sale	8.00	6,152	49,241	428,913	Jun 15 02:23 PM
Gottwald James T.	10% Owner	Jun 12 '26	Sale	8.16	20,146	164,452	408,767	Jun 15 02:19 PM
Gottwald James T.	10% Owner	Jun 11 '26	Sale	8.00	6,152	49,241	428,913	Jun 15 02:19 PM
GOTTWALD WILLIAM M	10% Owner	Jun 10 '26	Sale	8.04	15,809	127,025	435,064	Jun 11 02:30 PM
GOTTWALD WILLIAM M	10% Owner	Jun 09 '26	Sale	8.00	2,350	18,800	450,873	Jun 11 02:30 PM
Gottwald James T.	10% Owner	Jun 10 '26	Sale	8.04	15,808	127,017	435,065	Jun 11 02:25 PM
Gottwald James T.	10% Owner	Jun 09 '26	Sale	8.00	2,351	18,808	450,873	Jun 11 02:25 PM
GOTTWALD JOHN D	10% Owner	Jun 10 '26	Sale	8.04	15,808	127,017	435,065	Jun 11 02:17 PM
GOTTWALD JOHN D	10% Owner	Jun 09 '26	Sale	8.00	2,351	18,808	450,873	Jun 11 02:17 PM
Tack Carl E. III	Former Director	Jun 09 '26	Proposed Sale	8.00	7,911	63,288		Jun 09 12:59 PM
GOTTWALD JOHN D	10% Owner	Jun 05 '26	Sale	7.76	3,333	25,864	453,224	Jun 08 03:50 PM
GOTTWALD JOHN D	10% Owner	Jun 04 '26	Sale	8.00	33	264	456,557	Jun 08 03:50 PM
GOTTWALD WILLIAM M	10% Owner	Jun 05 '26	Sale	7.76	3,334	25,872	453,223	Jun 08 03:41 PM
GOTTWALD WILLIAM M	10% Owner	Jun 04 '26	Sale	8.00	33	264	456,557	Jun 08 03:41 PM
Gottwald James T.	10% Owner	Jun 05 '26	Sale	7.76	3,333	25,864	453,224	Jun 08 03:33 PM
Gottwald James T.	10% Owner	Jun 04 '26	Sale	8.00	34	272	456,557	Jun 08 03:33 PM
Tack Carl E. III	Director	Jun 04 '26	Proposed Sale	8.00	192	1,536		Jun 04 04:19 PM
GOTTWALD WILLIAM M	10% Owner	Jun 03 '26	Sale	7.77	848	6,589	456,590	Jun 04 01:30 PM
GOTTWALD WILLIAM M	10% Owner	Jun 02 '26	Sale	8.00	197	1,576	457,438	Jun 04 01:30 PM
GOTTWALD JOHN D	10% Owner	Jun 03 '26	Sale	7.77	847	6,581	456,590	Jun 04 01:26 PM
GOTTWALD JOHN D	10% Owner	Jun 02 '26	Sale	8.00	197	1,576	457,437	Jun 04 01:26 PM
Gottwald James T.	10% Owner	Jun 03 '26	Sale	7.77	847	6,581	456,591	Jun 04 01:23 PM
Gottwald James T.	10% Owner	Jun 02 '26	Sale	8.00	197	1,576	457,438	Jun 04 01:23 PM
Tack Carl E. III	Director	Jun 02 '26	Proposed Sale	8.00	314	2,512		Jun 02 04:26 PM
GOTTWALD JOHN D	10% Owner	May 28 '26	Sale	8.02	4,193	33,640	457,639	Jun 01 02:11 PM
GOTTWALD JOHN D	10% Owner	May 29 '26	Sale	8.00	5	40	457,634	Jun 01 02:11 PM
GOTTWALD WILLIAM M	10% Owner	May 28 '26	Sale	8.02	4,193	33,640	457,639	Jun 01 02:07 PM
GOTTWALD WILLIAM M	10% Owner	May 29 '26	Sale	8.00	4	32	457,635	Jun 01 02:07 PM
Gottwald James T.	10% Owner	May 28 '26	Sale	8.02	4,192	33,632	457,639	Jun 01 02:00 PM
Gottwald James T.	10% Owner	May 29 '26	Sale	8.00	4	32	457,635	Jun 01 02:00 PM
GOTTWALD JOHN D	10% Owner	May 27 '26	Sale	8.01	10,352	82,961	461,832	May 28 12:11 PM
GOTTWALD JOHN D	10% Owner	May 26 '26	Sale	8.00	10,144	81,162	472,184	May 28 12:11 PM
GOTTWALD WILLIAM M	10% Owner	May 27 '26	Sale	8.01	10,351	82,953	461,832	May 28 12:09 PM
GOTTWALD WILLIAM M	10% Owner	May 26 '26	Sale	8.00	10,144	81,162	472,183	May 28 12:09 PM
Gottwald James T.	10% Owner	May 27 '26	Sale	8.01	10,352	82,961	461,831	May 28 12:09 PM
Gottwald James T.	10% Owner	May 26 '26	Sale	8.00	10,144	81,162	472,183	May 28 12:09 PM
Tack Carl E. III	Director	May 27 '26	Proposed Sale	8.01	20,000	160,114		May 27 05:14 PM
GOTTWALD WILLIAM M	10% Owner	May 22 '26	Sale	8.00	120	960	482,327	May 26 12:20 PM
GOTTWALD WILLIAM M	10% Owner	May 21 '26	Sale	8.00	21	168	482,447	May 26 12:20 PM
GOTTWALD JOHN D	10% Owner	May 22 '26	Sale	8.00	120	960	482,328	May 26 12:10 PM
GOTTWALD JOHN D	10% Owner	May 21 '26	Sale	8.00	21	168	482,448	May 26 12:10 PM
Gottwald James T.	10% Owner	May 22 '26	Sale	8.00	120	960	482,327	May 26 12:03 PM
Gottwald James T.	10% Owner	May 21 '26	Sale	8.00	21	168	482,447	May 26 12:03 PM
Tack Carl E. III	Director	May 26 '26	Proposed Sale	8.00	5,000	40,000		May 26 10:12 AM
Newsome Kenneth	Former Director	May 22 '26	Proposed Sale	7.75	27,000	209,312		May 22 04:04 PM
DasGupta Arijit	See Remarks	May 21 '26	Buy	7.55	1,000	7,550	137,097	May 22 08:36 AM
Tack Carl E. III	Director	May 18 '26	Sale	7.81	5,435	42,447	73,421	May 20 05:47 PM
Newsome Kenneth	Former Director	May 19 '26	Proposed Sale	7.18	7,000	50,259		May 19 04:13 PM
Tack Carl E. III	Director	May 18 '26	Proposed Sale	7.81	5,435	42,451		May 18 04:25 PM
Newsome Kenneth	Former Director	May 18 '26	Proposed Sale	7.61	3,935	29,945		May 18 04:24 PM
GOTTWALD WILLIAM M	10% Owner	May 15 '26	Sale	8.01	7,384	59,131	482,468	May 18 01:25 PM
GOTTWALD WILLIAM M	10% Owner	May 14 '26	Sale	8.34	4,550	37,965	489,852	May 18 01:25 PM
GOTTWALD JOHN D	10% Owner	May 15 '26	Sale	8.01	7,383	59,123	482,469	May 18 01:19 PM
GOTTWALD JOHN D	10% Owner	May 14 '26	Sale	8.34	4,551	37,974	489,852	May 18 01:19 PM
Gottwald James T.	10% Owner	May 15 '26	Sale	8.01	7,384	59,131	482,468	May 18 01:11 PM
Gottwald James T.	10% Owner	May 14 '26	Sale	8.34	4,550	37,965	489,852	May 18 01:11 PM
Newsome Kenneth	Former Director	May 15 '26	Proposed Sale	8.15	1,501	12,233		May 15 04:06 PM
Newsome Kenneth	Former Director	May 14 '26	Proposed Sale	8.23	39,420	324,530		May 14 05:06 PM
GOTTWALD WILLIAM M	10% Owner	May 12 '26	Sale	8.62	25,355	218,484	499,268	May 14 03:25 PM
GOTTWALD WILLIAM M	10% Owner	May 13 '26	Sale	8.30	4,866	40,412	494,402	May 14 03:25 PM
Gottwald James T.	10% Owner	May 12 '26	Sale	8.62	25,355	218,484	499,268	May 14 03:21 PM
Gottwald James T.	10% Owner	May 13 '26	Sale	8.30	4,866	40,412	494,402	May 14 03:21 PM
GOTTWALD JOHN D	10% Owner	May 12 '26	Sale	8.62	25,356	218,493	499,268	May 14 03:15 PM
GOTTWALD JOHN D	10% Owner	May 13 '26	Sale	8.30	4,865	40,404	494,403	May 14 03:15 PM
Residual 10-Year CLAT UA FDGJR	10% Owner	May 12 '26	Proposed Sale	10.00	347,569	3,475,690		May 12 09:13 AM
GOTTWALD WILLIAM M	10% Owner	Feb 26 '26	Sale	8.99	12,007	107,955	529,438	Mar 02 03:03 PM
GOTTWALD WILLIAM M	10% Owner	Feb 27 '26	Sale	9.02	4,815	43,441	524,623	Mar 02 03:03 PM
GOTTWALD JOHN D	10% Owner	Feb 26 '26	Sale	8.99	12,008	107,964	529,438	Mar 02 03:00 PM
GOTTWALD JOHN D	10% Owner	Feb 27 '26	Sale	9.02	4,814	43,432	524,624	Mar 02 03:00 PM
Gottwald James T.	10% Owner	Feb 26 '26	Sale	8.99	12,008	107,964	529,438	Mar 02 02:58 PM
Gottwald James T.	10% Owner	Feb 27 '26	Sale	9.02	4,815	43,441	524,623	Mar 02 02:58 PM
Gottwald James T.	10% Owner	Feb 25 '26	Sale	8.99	28,787	258,824	541,446	Feb 26 04:57 PM
Gottwald James T.	10% Owner	Feb 24 '26	Sale	8.83	8,251	72,881	570,233	Feb 26 04:57 PM
GOTTWALD WILLIAM M	10% Owner	Feb 25 '26	Sale	8.99	28,788	258,833	541,445	Feb 26 04:50 PM
GOTTWALD WILLIAM M	10% Owner	Feb 24 '26	Sale	8.83	8,250	72,872	570,233	Feb 26 04:50 PM
GOTTWALD JOHN D	10% Owner	Feb 25 '26	Sale	8.99	28,787	258,824	541,446	Feb 26 04:45 PM
GOTTWALD JOHN D	10% Owner	Feb 24 '26	Sale	8.83	8,251	72,881	570,233	Feb 26 04:45 PM
Gottwald James T.	10% Owner	Feb 23 '26	Sale	8.80	4,461	39,270	578,484	Feb 24 12:42 PM
Gottwald James T.	10% Owner	Feb 20 '26	Sale	8.81	1,023	9,009	582,945	Feb 24 12:42 PM
GOTTWALD JOHN D	10% Owner	Feb 23 '26	Sale	8.80	4,461	39,270	578,484	Feb 24 12:37 PM

Open in Screener

MLCI

Mount Logan Capital Inc

3.11

Aug 18 • 3:59 PM ET 0.00 (0.00%)

Financial Asset Management USA Nano NASD

MLCI Mount Logan Capital Inc daily Stock Chart

Peers: GEG RMCO HNNA GROW GECC ICMB RAND PFX OFS TGE

| Held by: VTI VXF IWC

Index	-
Market Cap	34.80M
Enterprise Value	64.19M
Income	-63.36M
Sales	-7.62M
Book/sh	5.43
Cash/sh	7.21
Dividend Est.	0.12 (3.86%)
Dividend TTM	0.09 (2.89%)
Dividend Ex-Date	Aug 21, 2026
Dividend Gr. 3/5Y	-27.89% -17.81%
Payout	-
Employees	-
IPO	Sep 15, 2025

P/E	-
Forward P/E	20.06
PEG	-
P/S	-
P/B	0.57
P/C	0.43
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.14
Current Ratio	0.14
Debt/Eq	1.81
LT Debt/Eq	1.81
Option/Short	No / Yes

EPS (ttm)	-5.63
EPS next Y	0.15
EPS next Q	-0.19
EPS this Y	93.08%
EPS next Y	131.63%
EPS next 5Y	-
EPS past 3/5Y	- -96.89%
Sales past 3/5Y	- -
EPS Y/Y TTM	-447.95%
Sales Y/Y TTM	44.90%
EPS Q/Q	-217.43%
Sales Q/Q	-43.17%
Earnings	Aug 11 AMC
EPS/Sales Surpr.	-3800.00% -33.22%

Insider Own	8.41%
Insider Trans	1.30%
Inst Own	22.14%
Inst Trans	-5.41%
ROA	-3.86%
ROE	-118.90%
ROIC	-37.09%
Gross Margin	457.13%
Oper. Margin	1202.75%
Profit Margin	830.89%
SMA20	1.66%
SMA50	-1.43%
SMA200	-41.07%
Trades

Shs Outstand	11.19M
Shs Float	10.25M
Short Float	1.03%
Short Ratio	3.06
Short Interest	0.11M
52W High	8.74 -64.44%
52W Low	2.56 21.48%
Volatility	11.58% 6.01%
ATR (14)	0.21
RSI (14)	50.24
Beta	-
Rel Volume	0.00
Avg Volume	34.36K
Volume	0

Perf Week	9.12%
Perf Month	-6.33%
Perf Quarter	-6.33%
Perf Half Y	-44.96%
Perf YTD	-62.30%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	8.50
Prev Close	3.11
Price	3.11
Change %	0.00%

Aug-13-26 08:00AM	Mount Logan Capital Inc. Establishes Direct Insurance Origination (GlobeNewswire) +13.21%
Aug-12-26 07:00PM	Mount Logan Capital Inc (MLCI) (Q2 2026) Earnings Call Highlights: Strategic Inflection Point ... (GuruFocus.com) -7.02%
01:19PM	Mount Logan Capital Inc. Common Stock Q2 2026 Earnings Call Summary (Moby)
Aug-11-26 05:05PM	Mount Logan Capital Inc. Announces Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-05-26 04:15PM	Mount Logan Capital Inc. Schedules Release of Second Quarter 2026 Results (GlobeNewswire)
08:00AM	Loading…
Jul-27-26 08:00AM	Mount Logan Capital Inc. Announces Receipt of AM Best Rating for Ability Insurance Company (GlobeNewswire)
Jun-26-26 08:00AM	Mount Logan Capital Inc. to Join the Russell Microcap Index (GlobeNewswire) +11.14%
May-14-26 04:20PM	Mount Logan Capital Inc. Announces First Quarter 2026 Financial Results (GlobeNewswire) -6.38%
May-11-26 08:00AM	Mount Logan Capital Inc. Schedules Release of First Quarter 2026 Results (GlobeNewswire)
Apr-15-26 04:15PM	Mount Logan Capital Inc. to Participate in the B. Riley Securities, Inc. 2026 Annual Investor Conference (GlobeNewswire)
Mar-19-26 07:00PM	Mount Logan Capital Inc (MLCI) Q4 2025 Earnings Call Highlights: Strategic Acquisitions and ... (GuruFocus.com) -13.92%
07:30AM	Mount Logan Capital Inc. Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:29AM	Mount Logan-Managed Opportunistic Credit Interval Fund (SOFIX) to Acquire $100+ Million of Assets from Yieldstreet Alternative Income Fund (YS AIF) (GlobeNewswire)
Feb-23-26 08:00AM	Mount Logan Capital Inc. Announces $10 Million Share Repurchase Program (GlobeNewswire)
Feb-10-26 08:00AM	Mount Logan Capital Inc. Announces Leadership Update (GlobeNewswire)
08:00AM	Loading…
Feb-06-26 08:00AM	Mount Logan Capital Inc. Announces Final Results of Tender Offer (GlobeNewswire)
Feb-04-26 04:15PM	Mount Logan Capital Inc. Announces Preliminary Results of Tender Offer (GlobeNewswire) -9.29%
Jan-16-26 07:00AM	Mount Logan Capital Inc. Prices $40.0 Million Senior Notes Offering (GlobeNewswire)
Jan-14-26 08:15AM	Mount Logan Capital Inc. Announces Offering of Senior Notes (GlobeNewswire)
Dec-29-25 09:00AM	Mount Logan Capital Inc. Commences Self Tender Offer to Purchase up to an Aggregate $15 Million of its Common Stock (GlobeNewswire)
Dec-11-25 08:00AM	Mount Logan Capital Inc. Initiates Shareholder Record Search relating to expected $15 Million Tender Offer (GlobeNewswire) +8.31%
Dec-02-25 09:00AM	Mount Logan Capital Inc. to Participate in the Northland Capital Markets Growth Conference on December 16, 2025 (GlobeNewswire)
Nov-14-25 04:04PM	Mount Logan Capital Inc (MLCI) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
Nov-13-25 05:30PM	Mount Logan Capital Inc. Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-12-25 08:00AM	Mount Logan Capital Inc. Schedules Release of Third Quarter 2025 Results (GlobeNewswire)

Mount Logan Capital, Inc. operates as an investment company. It engages in the facilitation of business mergers. The company was founded on January 7, 2025 and is headquartered in Montclair, NJ.

CEO & Chairman of the BoardMr. Edward Joseph Goldthorpe

PresidentMr. Henry Han-Wei Wang

CFO & Corporate SecretaryMr. Brandon Satoren

Executive VP & COOMr. Jordan Mangum

Chief Compliance OfficerMr. David Isaac Held J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Satoren Brandon	Chief Financial Officer	Aug 17 '26	Buy	3.13	1,000	3,130	18,814	Aug 18 05:27 PM
Satoren Brandon	Chief Financial Officer	Aug 18 '26	Buy	3.02	1,000	3,020	19,814	Aug 18 05:27 PM
Goldthorpe Edward J.	Chief Executive Officer	Jun 22 '26	Buy	2.77	7,970	22,077	297,339	Jun 23 08:50 AM
Mangum Jordan	Chief Operating Officer	May 26 '26	Buy	3.43	2,115	7,250	10,000	May 27 07:16 PM

RVSB Riverview Bancorp Inc daily Stock Chart

Peers: BOTJ BSBK HYNE LARK LSBK MGYR PROV SFBC UNB WSBK

| Held by: VTI VXF DFAT BSVO DFSV AVUV IWC FDM DFMC DFAS

Index	-
Market Cap	102.56M
Enterprise Value	-
Income	-3.87M
Sales	65.93M
Book/sh	7.20
Cash/sh	-
Dividend Est.	0.08 (1.56%)
Dividend TTM	0.08 (1.56%)
Dividend Ex-Date	Jul 09, 2026
Dividend Gr. 3/5Y	-30.66% -16.74%
Payout	-
Employees	243
IPO	Oct 25, 1993

P/E	-
Forward P/E	13.89
PEG	-
P/S	1.56
P/B	0.71
P/C	-
P/FCF	7.38
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	1.22
Debt/Eq	0.34
LT Debt/Eq	0.22
Option/Short	Yes / Yes

EPS (ttm)	-0.19
EPS next Y	0.37
EPS next Q	0.07
EPS this Y	33.33%
EPS next Y	32.14%
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	-1.55% 1.73%
EPS Y/Y TTM	-176.24%
Sales Y/Y TTM	-11.21%
EPS Q/Q	42.47%
Sales Q/Q	6.30%
Earnings	Jul 28 AMC
EPS/Sales Surpr.	14.29% 1.45%

Insider Own	4.20%
Insider Trans	0.18%
Inst Own	66.35%
Inst Trans	-8.54%
ROA	-0.26%
ROE	-2.52%
ROIC	-2.19%
Gross Margin	-
Oper. Margin	-7.97%
Profit Margin	-5.87%
SMA20	-3.17%
SMA50	-5.29%
SMA200	-4.05%
Trades

Shs Outstand	20.16M
Shs Float	19.12M
Short Float	1.41%
Short Ratio	2.57
Short Interest	0.27M
52W High	6.22 -17.36%
52W Low	4.74 8.44%
Volatility	2.11% 2.13%
ATR (14)	0.12
RSI (14)	36.32
Beta	0.47
Rel Volume	0.00
Avg Volume	104.97K
Volume	0

Perf Week	-3.02%
Perf Month	-2.10%
Perf Quarter	-5.86%
Perf Half Y	-3.75%
Perf YTD	2.39%
Perf Year	4.05%
Perf 3Y	-13.61%
Perf 5Y	-30.91%
Perf 10Y	1.98%
Recom	2.00
Target Price	7.00
Prev Close	5.14
Price	5.14
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-16	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-24-12	Downgrade	Wunderlich	Hold → Sell	$2 → $1
Dec-05-11	Downgrade	Wunderlich	Buy → Hold	$4 → $2.50
Aug-09-10	Initiated	Wunderlich	Buy	$3.50
Feb-08-08	Downgrade	DA Davidson	Neutral → Underperform	$11

Aug-10-26 04:00PM	Michael Sventek, EVP and CLO, Announces Retirement from Riverview Bancorp, Inc. (GlobeNewswire)
Jul-28-26 04:10PM	Riverview Bancorp: Fiscal Q1 Earnings Snapshot (Associated Press)
04:00PM	Riverview Bancorp Reports Net Income of $1.7 Million in First Quarter 2027 (GlobeNewswire)
Jun-26-26 09:00AM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Apr-28-26 08:28AM	Riverview Bancorp: Fiscal Q4 Earnings Snapshot (Associated Press)
08:00AM	Loading…
08:00AM	Riverview Bancorp Reports Fiscal Fourth Quarter 2026 and Fiscal Year 2026 Results (GlobeNewswire)
Apr-02-26 09:00AM	Kourosh Zamani and Jon Girod Join Riverview Bancorp Board of Directors (GlobeNewswire)
Mar-31-26 04:32PM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Mar-25-26 09:00AM	Riverview Bank Announces Strategic Balance Sheet Optimization (GlobeNewswire)
Jan-28-26 04:00PM	Riverview Bancorp, Inc. Announces $4.0 Million Stock Repurchase Program (GlobeNewswire)
Jan-27-26 05:10PM	Riverview Bancorp (RVSB) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:07PM	Riverview Bancorp: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Reports Net Income of $1.4 Million in Third Fiscal Quarter 2026 (GlobeNewswire)
Jan-22-26 09:10AM	Heritage Financial (HFWA) Q4 Earnings and Revenues Top Estimates (Zacks)
Dec-23-25 04:00PM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
09:00AM	Loading…
Nov-25-25 09:00AM	Is the Options Market Predicting a Spike in Riverview Bancorp Stock? (Zacks)
Oct-28-25 05:10PM	Riverview Bancorp (RVSB) Lags Q2 Earnings Estimates (Zacks)
04:14PM	Riverview Bancorp: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Reports Net Income of $1.1 Million in Second Fiscal Quarter 2026 (GlobeNewswire)
Oct-22-25 05:35PM	OceanFirst Financial (OCFC) Tops Q3 Earnings and Revenue Estimates (Zacks)
Sep-29-25 04:00PM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Sep-27-25 10:24AM	Riverview Bancorp (RVSB)'s CFO David Lam Buys 1,000 Shares at $4.93 Each, Worth $4,930 (Insider Monkey)
Aug-27-25 09:00AM	Riverview Bancorp Announces Appointment of Graham Clancy as Director of Finance and Promotes Phung Le to Controller (GlobeNewswire)
Jul-29-25 05:15PM	Riverview Bancorp (RVSB) Surpasses Q1 Earnings Estimates (Zacks)
04:18PM	Riverview Bancorp: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Reports Net Income of $1.2 Million in First Fiscal Quarter 2026 (GlobeNewswire)
Jul-01-25 09:00AM	Riverview Bancorp, Inc. Added to Russell 2000 Index (GlobeNewswire)
Jun-27-25 09:00AM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Jun-18-25 09:11AM	Zacks Industry Outlook Highlights WSFS Financial, Provident Financial Services and Riverview Bancorp (Zacks)
Jun-17-25 10:13AM	3 Solid Stocks to Bet on From the Prospering Savings & Loan Industry (Zacks)
10:10AM	Loading…
Apr-29-25 10:10AM	Riverview Bancorp (RVSB) Beats Q4 Earnings and Revenue Estimates (Zacks)
09:17AM	Riverview Bancorp: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
09:01AM	Riverview Bancorp, Inc. Announces Stock Repurchase Program (GlobeNewswire)
09:00AM	Riverview Bancorp Reports Net Income of $1.1 Million in Fourth Fiscal Quarter 2025 and $4.9 Million for Fiscal 2025 (GlobeNewswire)
Apr-23-25 05:20PM	Pacific Premier Bancorp (PPBI) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Apr-12-25 11:00AM	Goldman Sachs, J&J, To Report Earnings As Investors Watch Out For Retail Sales Data (Seeking Alpha)
Apr-02-25 04:00PM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Jan-30-25 06:05PM	Riverview Bancorp (RVSB) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
05:02PM	Riverview Bancorp: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Reports Net Income of $1.2 Million in Third Fiscal Quarter 2025; Results Highlighted by Net Interest Margin Expansion (GlobeNewswire)
Jan-09-25 09:00AM	Charmaine Lightheart named EVP/Chief Retail and Digital Engagement Officer (GlobeNewswire)
Dec-23-24 03:17PM	CORRECTION: Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
09:00AM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Oct-24-24 05:10PM	Riverview Bancorp (RVSB) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:09PM	Riverview Bancorp: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Reports Net Income of $1.6 Million in Second Fiscal Quarter 2025 (GlobeNewswire)
Sep-26-24 04:00PM	Riverview Bancorp, Inc. Announces Stock Repurchase Program (GlobeNewswire)
04:00PM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Jul-25-24 10:53PM	RVSB Stock Earnings: Riverview Bancorp Misses EPS, Misses Revenue for Q1 2025 (InvestorPlace)
05:10PM	Riverview Bancorp (RVSB) Q1 Earnings and Revenues Lag Estimates (Zacks)
04:07PM	Riverview Bancorp: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Reports First Fiscal Quarter 2025 Financial Results (GlobeNewswire)
Jul-01-24 11:39AM	Why Are Analysts Bullish on Riverview Bancorp, Inc. (RVSB) Right Now? (Insider Monkey)
Jun-28-24 09:00AM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share (GlobeNewswire)
Jun-24-24 07:01AM	Riverview Bank taps M&A expert as next CEO (Banking Dive)
Jun-21-24 09:40AM	Are Investors Undervaluing Riverview Bancorp (RVSB) Right Now? (Zacks)
09:00AM	Nicole Sherman Named President and Chief Executive Officer of Riverview Bancorp (GlobeNewswire)
Jun-05-24 09:40AM	Should Value Investors Buy Riverview Bancorp (RVSB) Stock? (Zacks)
May-16-24 09:40AM	Are Investors Undervaluing Riverview Bancorp (RVSB) Right Now? (Zacks)
Apr-30-24 09:40AM	Is Riverview Bancorp (RVSB) Stock Undervalued Right Now? (Zacks)
Apr-25-24 09:54PM	RVSB Stock Earnings: Riverview Bancorp Beats EPS, Misses Revenue for Q4 2024 (InvestorPlace)
05:02PM	Riverview Bancorp: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:25PM	Riverview Bancorp Reports Fourth Fiscal Quarter 2024 and Fiscal Year 2024 Financial Results; Announces Balance Sheet Restructuring (GlobeNewswire)
Apr-01-24 09:00AM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share (GlobeNewswire)
Jan-25-24 05:20PM	Riverview Bancorp (RVSB) Q3 Earnings and Revenues Miss Estimates (Zacks)
04:18PM	Riverview Bancorp: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:04PM	Riverview Bancorp Earns $1.5 Million in Third Fiscal Quarter 2024 (GlobeNewswire)
Dec-26-23 04:00PM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share (GlobeNewswire)
Oct-26-23 05:15PM	Riverview Bancorp (RVSB) Meets Q2 Earnings Estimates (Zacks)
04:17PM	Riverview Bancorp: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Earns $2.5 Million in Second Fiscal Quarter 2024 (GlobeNewswire)
Oct-23-23 06:15PM	Southern Missouri Bancorp (SMBC) Beats Q1 Earnings Estimates (Zacks)
Oct-02-23 04:00PM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share (GlobeNewswire)
Aug-22-23 09:00AM	Riverview Bancorp Announces Executive Management Promotions: Promotes Daniel Cox to Chief Operating Officer & Robert Benke to EVP/Chief Credit Officer; Announces Michael Sventek as EVP/Chief Lending Officer (GlobeNewswire)
Aug-09-23 12:59PM	Change of Leadership at Riverview Bank (GlobeNewswire)
Jul-27-23 05:35PM	Riverview Bancorp (RVSB) Q1 Earnings Match Estimates (Zacks)
04:28PM	Riverview Bancorp: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Riverview Bancorp Earns $2.8 Million in First Fiscal Quarter 2024 (GlobeNewswire)
Jul-20-23 06:26AM	Strength Seen in Riverview Bancorp (RVSB): Can Its 5.7% Jump Turn into More Strength? (Zacks)
Jul-17-23 04:50PM	12 Best Dividend Stocks Under $10 (Insider Monkey)
Jul-04-23 06:02AM	Riverview Bancorp (NASDAQ:RVSB) Is Due To Pay A Dividend Of $0.06 (Simply Wall St.)
Jun-30-23 09:00AM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share (GlobeNewswire)
May-31-23 07:14AM	With 53% institutional ownership, Riverview Bancorp, Inc. (NASDAQ:RVSB) is a favorite amongst the big guns (Simply Wall St.)
May-09-23 07:04PM	Riverview Bank Celebrates Its 100-Year Anniversary (GlobeNewswire)
Apr-30-23 08:39AM	Multiple insiders bought Riverview Bancorp, Inc. (NASDAQ:RVSB) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Apr-27-23 07:15PM	Riverview Bancorp (RVSB) Lags Q4 Earnings and Revenue Estimates (Zacks)
06:17PM	Riverview Bancorp: Fiscal Q4 Earnings Snapshot (AP Finance)
05:27PM	Riverview Bancorp Earns $3.0 Million in Fourth Fiscal Quarter 2023 and $18.1 Million for Fiscal Year 2023 (GlobeNewswire)
Apr-26-23 09:05PM	Northfield Bancorp (NFBK) Q1 Earnings and Revenues Miss Estimates (Zacks)
Apr-25-23 06:55PM	Flushing Financial (FFIC) Q1 Earnings and Revenues Lag Estimates (Zacks)
Apr-21-23 10:00AM	Analysts Estimate New York Community Bancorp (NYCB) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-20-23 10:03AM	Riverview Bancorp (RVSB) to Report Q4 Results: What to Know Ahead of the Release (Zacks)
Apr-12-23 07:26AM	Riverview Bancorp (RVSB) Stock Jumps 5.5%: Will It Continue to Soar? (Zacks)
Apr-03-23 06:44AM	Riverview Bancorp (NASDAQ:RVSB) investors are sitting on a loss of 33% if they invested five years ago (Simply Wall St.)
Mar-27-23 09:00AM	Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share (GlobeNewswire)
Jan-31-23 08:43AM	Riverview Bancorp Third Quarter 2023 Earnings: In Line With Expectations (Simply Wall St.)
Jan-26-23 05:15PM	Riverview Bancorp (RVSB) Meets Q3 Earnings Estimates (Zacks)
04:00PM	Riverview Bancorp Earns $5.2 Million in Third Fiscal Quarter 2023; Results Highlighted by Net Interest Margin Expansion (GlobeNewswire)
Dec-27-22 09:40AM	Should Value Investors Buy Riverview Bancorp (RVSB) Stock? (Zacks)
Dec-25-22 07:31AM	Riverview Bancorp (NASDAQ:RVSB) Is Due To Pay A Dividend Of $0.06 (Simply Wall St.)

Riverview Bancorp, Inc. operates as a holding company. It provides community banking services to small and medium size businesses, professionals, and individuals. It offers a range of deposit products, including demand deposits, negotiable order of withdrawal accounts, money market accounts, savings accounts, certificates of deposit, and retirement savings plans. The company also provides commercial business, commercial real estate, other real estate mortgage, and real estate construction loans, and consumer loans, such as one-to-four family mortgage loans, home equity lines of credit, land loans, and other secured and unsecured consumer loans. In addition, it is involved in the provision of brokerage and mortgage loan servicing activities, as well as offering asset management services consisting of trust, estate planning, and investment management services. The company was founded on June 23, 1997 and is headquartered in Vancouver, WA.

PresidentMs. Nicole B. Sherman

Executive VP & COOMr. Daniel D. Cox

President and Chief Executive Officer of Riverview Trust CompanyMr. Courtney Evan Sowers M.B.A.

Executive VP & CFOMr. David Lam CPA

Executive VP & Chief Lending Officer of Riverview BankMr. Steven P. Plambeck

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lam David	EVP/CFO	Aug 17 '26	Buy	5.17	1,000	5,170	76,011	Aug 18 03:37 PM
Lightheart Charmaine	EVP/CRDEO	Aug 12 '26	Buy	5.31	250	1,327	8,766	Aug 13 12:13 PM
Girod Jon Louis	Director	Aug 03 '26	Buy	5.41	1,000	5,408	3,000	Aug 05 11:48 AM
Girod Jon Louis	Director	Jul 31 '26	Buy	5.24	2,000	10,478	2,000	Aug 03 12:30 PM
Nierenberg Investment Manageme	10% Owner	Jul 24 '26	Sale	5.29	5,000	26,450	79,388	Jul 24 06:32 PM
Nierenberg Investment Manageme	10% Owner	Jul 23 '26	Sale	5.27	5,000	26,350	84,388	Jul 24 06:32 PM
Nierenberg Investment Manageme	10% Owner	Jul 22 '26	Sale	5.25	5,000	26,250	89,388	Jul 24 06:32 PM
Lightheart Charmaine	EVP/CRDEO	Jun 01 '26	Buy	5.54	150	831	8,516	Jun 02 04:23 PM
Lightheart Charmaine	EVP/CRDEO	May 29 '26	Buy	5.59	26	145	8,366	Jun 02 04:23 PM
Benke Robert	EVP/CCO	May 08 '26	Buy	5.44	4,000	21,760	47,984	May 11 10:15 AM
Sherman Nicole	President/CEO	May 07 '26	Buy	5.49	1,800	9,876	164,717	May 08 01:06 PM
Hoff Larry	Director	May 05 '26	Buy	5.21	1,920	10,013	14,020	May 07 04:32 PM
Cox Daniel D	EVP/COO	May 04 '26	Buy	5.22	1,000	5,220	70,008	May 05 08:00 AM
Lightheart Charmaine	EVP/CRDEO	Mar 05 '26	Buy	5.36	325	1,742	14,893	Mar 09 08:50 AM
Wills Bessie Ross	Director	Feb 18 '26	Buy	5.39	3,000	16,161	48,000	Feb 20 04:40 PM
Sherman Nicole	President/CEO	Dec 05 '25	Buy	5.12	975	4,992	187,674	Dec 10 07:52 AM
Lam David	EVP/CFO	Sep 12 '25	Buy	4.93	1,000	4,930	72,134	Sep 16 04:05 PM
Sherman Nicole	President/CEO	Aug 26 '25	Buy	5.04	1,475	7,434	161,991	Aug 26 03:12 PM

REZI

NTHI

VRCA

AMRZ

ELAN

SRI

ACON

TG

MLCI

Mount Logan Capital Inc

RVSB

Upgrade your Finviz experience